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ABSTRACT 
The ultra trace detection of both simple and large organic 
biomolecules is sought after for many different applications. The aim of this 
research was to develop a simple, rapid and cost-effective technique for the 
detection of ultra trace amounts of simple organic molecules as well as 
complex biomolecules, using functionalised Surface Enhanced Raman 
Spectroscopy (SERS).  Two models were developed using caffeine and 
erythropoietin (EPO) respectively.  
Caffeine, the world’s most widely used legal stimulant, is found in both 
beverages and pharmaceuticals.  With its ubiquity, its assay is an important 
chemical analysis.  Caffeine serves as an excellent simple organic molecule 
exemplar for this analytical technique.   
Erythropoietin is a complex protein hormone produced by the kidneys 
to initiate red blood cell production and found in blood serum and urine.  
Detection and quantification of both human EPO and recombinant human 
EPO (rHuEPO) is required for medical purposes.  Their distinction is also 
required, as rHuEPO is banned by both the World Anti-Doping Agency 
(WADA) and in animal racing.  RHuEPO’s proscribed use by athletes has been 
well documented in several infamous cases, e.g., in cycling.  As a complex 
protein, EPO is also a valuable complex biomolecule exemplar for this 
technique. 
For this work, antibody functionalised nanoparticles were developed 
and characterized, reacted with the analyte solutions, and then characterized 
by Raman spectroscopy.  This thesis presents the results of the nanoparticle 
characterization, the Raman spectra, and the univariate statistical and/or 
chemometrics analysis.  
It demonstrates the ability of this new technique to detect ultra low 
levels of the nominated analytes with significant improvement over existing 
methods. Caffeine detection was improved from 2×10-4 g (FT-Raman) down 
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to 2×10-13 g. The detection of EPO improved from 7×10-11 g (IEF) down to 
3×10-16 g. 
This novel technique quantifies the analytes in trace amounts, 
encompassing those levels required for the analysis of the nominated 
analytes (2×10-10 M to 3.5×10-13 M for EPO and 1×10-4 M to 1×10-9 M for 
caffeine), with application in many fields (such as, food analysis, clinical 
diagnostics, and in the racing and sports industries). Moreover it 
distinguishes between human EPO and rHuEPO, with a substantial 
improvement on current techniques, 71% (IEF) and 40% (MAIIA); 
distinguishing rHuEPO in urine at 2.5% of the total EPO. And so has 
widespread applicability for the ultra trace analysis of biomolecules. 
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Chapter 1: Introduction 
1.1 BACKGROUND TO ANALYTICAL METHOD USED 
1.1.1 Historical Background 
Discovery of the Raman Effect 
The phenomenon that is now known as the ‘Raman Effect’, which refers to 
light that has been inelastically scattered upon encountering molecules of 
interacting substances, was discovered and elucidated early in the 20th century. 
C.V. Raman, for whom it is named, became interested in the molecular scattering 
of light after reading Professor Joseph Larmor’s paper, ‘Molecular Scattering of 
Radiation’.  He was also inspired by the work of Lord Rayleigh and his son, who 
proposed that the colour of the sea was simply a reflection of the colour of the 
sky [1].  
Attempting to confirm Rayleigh’s theory, Raman performed a simple 
experiment by observing the ocean through a Nicol prism in such a way that 
excluded reflection of light from the sky.  He found that the sea’s blue colour was 
not extinguished by this experiment, thus disproving the Rayleigh’s theory.  This 
observation laid the foundation for his future work, which led to the ultimate 
discovery of the Raman Effect [1].  Raman’s initial experiments elucidating the 
molecular scattering of light employed concentrated sunlight and a pair of 
complimentary filters [fig.1.1.1]. Later an 18 cm telescope (short focus) objective 
lens was used to focus the light, and a direct vision spectroscope was used to 
view the emerging light.  
A series of over 80 different liquids (aromatic, aliphatic and inorganic), 
several gases (ether and pentene vapours, CO2 and N2O) and ice crystals were 
examined.  New polarized light beams that were not present in the  incident 
beam were detected for each substance, and the scattered light had less energy 
than the incident light; and a gap of unoccupied space between the non-
scattered and scattered light rays was visible through the direct vision 
spectroscope. Even the most careful experimental work could not extinguish 
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these effects, so they concluded that this phenomenon was characteristic of each 
substance [1].  The initial discovery of polarised scattered light, the consistent 
loss of energy in the scattered light, and the weak effect of the scattered light all 
pointed to a hitherto unknown phenomenon, which was the optical equivalent of 
the Compton Effect [1]. 
In his first experimental observation confirming the ‘Raman Effect’, made 
on February 28, 1928, Raman used a monochromatic mercury arc lamp as the 
light source. (All visible light except that above indigo at 4358 Å was excluded by 
this lamp.)  He used a direct vision spectroscope to view the emerging light.  This 
showed several sharp blue/green lines, with a remarkable similarity in wavelength 
between related chemicals, i.e. pentane, heptane and octane [1]. He also showed 
that the difference in wavelength of the scattered light due to toluene was 
equivalent to its infrared (IR) absorbance, and that different molecules produced 
different wavelength shifts [1]. 
Raman was internationally credited with the discovery of the effect, which 
led to his election as Fellow of the Royal Society in 1924,[2] the granting of his 
knighthood in 1929 [1] and the Nobel Prize for physics in 1930. His Nobel prize 
Figure 1.1.1 Experimental design for Raman’s early experiments 
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was awarded "for his work on the scattering of light and for the discovery of the 
effect named after him" [3]. His Nobel Lecture was entitled “The Molecular 
Scattering of Light” [4].   
Chemists recognised the technique as a valuable analytical tool, and 
during this time 2500 different chemical compounds were studied using it, but its 
popularity waned due to the technical limitations associated with the arc lamp 
light source.  The development of lasers in the 1960s as an intense coherent light 
source led to a resurgence in Raman research [1].  The Surface Enhanced Raman 
Spectroscopy (SERS) technique described in this thesis was accidentally 
discovered in 1974 by Fleischmann, et al [5].  
The Surface Enhanced Raman Spectroscopy (SERS) Innovation 
Fleischmann and his colleagues used pyridine deposited on a silver 
electrode in an attempt to use the Raman Effect to study a single molecular layer 
of analyte.  To increase the surface area, they electro-chemically roughened a 
silver electrode.  They ascribed the enhanced Raman signal that they observed to 
this increased surface area [5, 6].  The mechanism of enhancement was 
subsequently described and recognised as what is now known as the SERS effect, 
following its initial description in the late 1970s. 
The first indication of the importance of Fleischmann’s discovery was 
noted with the publication in the Journal of the American Chemical Society in July 
1977 [7, 8] by M.G. Albrecht and J.A. Creighton. In November of the same year 
R.P. Van Duyne and D.L. Jeanmarie also published their findings on surface 
enhanced Raman spectroscopy in the Journal of Electroanalytical Chemistry [8, 
9].  These two articles’ theoretical explanations of the enhanced Raman signal 
were the foundation of the two current competing explanations for the SERS 
effect. 
Since that time there have been several waves of interest in this research 
topic.  The first upsurge in research interest in this topic was an intense research 
effort that refined the methodology and largely refined theory behind it.  A 
second groundswell in SERS research activity started in the late 1990s, and the 
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publication of articles about SERS has grown exponentially since approximately 
2000, led by improvement in instrumentation, the ‘nano’ revolution, and the 
enticement of single molecule detection [5, 10]. 
The SERS enhancement of spectral intensity led to the development of 
Raman spectroscopy for single molecule detection (SM SERS).  Several 
laboratories have since independently claimed success [11].  
Many technical developments have also supported the rise in Raman 
spectroscopy.  Since their initial availability in the 1960s, lasers have continuously 
developed, increased in accuracy and flexibility and have diminished in size.  This 
has allowed portable instrumentation to be developed [8]. Raman spectroscopy 
can now be performed outside the laboratory when required.  So what is Raman 
spectroscopy?   
 
1.1.2 A background in Raman Spectroscopy 
When light interacts with matter, the majority of light that is scattered by 
the molecules is done so elastically; i.e. no energy is lost in the process and the 
angle of the emitted and incident light are conserved.  This is commonly known 
as Raleigh scattering.  
Only very few of the incident photons that interact with the substance 
molecules will lose or gain energy before being re-emitted. In such cases, the 
angle between the incident and emitted light is no longer conserved.  Inelastically 
scattered light is called Raman scattering, and energy loss is more common than 
energy gain.  These two types of inelastic scattering are called Raman Stokes 
scattering and Raman Anti-Stokes scattering, respectively [Fig. 1.1.2].   
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The difference between the energy of the incident and emitted light in 
Raman scattering is neither random nor continuous.  Rather, the quantum of 
energy that is absorbed or donated by the molecules reflects the status of the 
electrons in the bonds between the atoms of the molecules.  Analysis of the 
energy differences is therefore diagnostic of the molecule, and can detect very 
subtle differences in molecular structure.  In this way it forms a ‘molecular 
fingerprint’ of the molecule.  
In general, fluorescence emission accompanies the Raman emission.  
Fluorescence is caused when the energy of the incident light undergoes rapid 
non-radiative decay, i.e. losing some energy as heat, before the incident photons 
are re-emitted [Fig 1.1.2]. Fluorescence emission is much stronger than Raman 
scattering and will swamp the relatively weak Raman signal for many samples. 
This limits the use of Raman spectroscopy.   
Figure 1.1.2 Simplified Jablonski diagram of energy transitions in molecules 
with the absorption and emittance of light, comparing elastic-Rayleigh 
scattering, inelastic-Raman Stokes and anti-Stokes scattering and 
fluorescence.  The arrow pointing up is the energy of incident light with the 
arrow pointing down the energy of the emitted light.   
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As with all vibrational spectroscopy, not all molecules can be detected 
using Raman scattering. A Raman active molecule must have anisotropic 
polarizability to respond to incident light and generate Raman photons. The 
absorbed energy then induces a dipole moment in the molecules’ bonds.  The 
induction of a dipole moment within the molecule determines whether the 
molecule is ‘visible’ or ‘invisible’ to Raman. 
Mid-infrared spectroscopy is complimentary to Raman Spectroscopy.  Mid-
infrared spectroscopy requires a permanent dipole in the molecule, whereas 
Raman spectroscopy induces a temporary dipole. Importantly, water is essentially 
‘invisible’ in Raman spectroscopy, as it is already very polar.  This means that 
Raman spectroscopy can be performed directly on analytes in aqueous solutions 
including biological fluids. This is a significant advantage when compared to 
infrared spectroscopy where trace amounts of water interfere with the analysis. 
Raman spectroscopy is generally characterized by sharp bands of good 
resolution, which makes the technique ideal for the distinction of closely related 
molecules such as structural isomers. 
However, because Raman is such a weak effect, many molecules do not 
react strongly enough to be detected.  Surface Enhanced Raman Spectroscopy 
(SERS) is a modified Raman technique that overcomes much of this difficulty.   
 
1.1.3 Surface Enhanced Raman spectroscopy 
 Surface Enhanced Raman Spectroscopy (SERS) is a Raman Spectroscopic 
technique that greatly enhances Raman signals from Raman-active analyte 
molecules that have been adsorbed onto certain specially prepared metal 
surfaces[8]. SERS is observed primarily for analytes adsorbed onto coinage 
metals (Au, Ag and Cu) with the excitation wavelength in the near infrared (NIR) 
or visible region. Alkali (Li, Na, and K) metal surfaces have been proposed as 
even better enhancers, but their applicability is limited owing to their extreme 
reactivity with water. For excitation in the near ultraviolet region, Pd and Pt 
facilitate signal enhancements of about 102 - 103 fold.  
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Two primary explanations for SERS enhancement compete in the 
literature: an electromagnetic enhancement, based on the original interpretation 
by Van Duyne and his group [8, 9], and a Chemical Enhancement, as initially 
proposed by Albrecht and Creighton [7, 8].  
 Chemical Enhancement results from the interaction of analyte with the 
metallic surface to form a charge transfer complex. The metal-analyte proximity 
may allow pathways of electronic coupling from which novel charge-transfer 
intermediates emerge that have higher Raman scattering cross-sections than 
does the analyte when not adsorbed onto the surface.  This effect it is limited to 
molecules that can chemically bond to the metallic surface. 
The greater part of the overall enhancement of SERS is believed to be due 
to an electromagnetic enhancement mechanism that is a direct consequence of 
roughness of the metal surface. These features can be developed in a number of 
ways; for example: oxidation-reduction cycles on electrode surfaces; vapour 
deposition of metal particles onto substrate; metal spheroid assemblies produced 
via lithography; metal colloids; and, metal deposition over a deposition mask of 
polystyrene nanospheres. All of these methods leave the metal surface with small 
metal particles or aggregates of particles that serve as metal roughness features. 
The electromagnetic field at the particle’s roughness results in an electromagnetic 
enhancement caused by the resonance oscillation of the free electrons on the 
metallic surface with the incident light.  This forms an electric field at the particle 
surface called the localised surface plasmon resonance (LSPR) [8]. 
When the analyte molecule is within the effective range of the LSPR, the 
large electric field induces a dipole moment in the molecules, which yields the 
SERS enhancement [8].  The LSPR and the consequent SERS enhancement is 
only observed very close to the nanoparticle surface, and exponentially decays 
with increasing distance from the surface,  with the effective range <10 nm [12]. 
The SERS enhancement can be as large as 105 - 106 fold [7, 9].  
If multiple metallic nanoparticles are close enough together, their LSPR will 
merge and exhibit exponential enhancement.  This can increase the 
enhancement of the SERS up to 1012 fold.  These regions of extraordinary 
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enhancement are known as ‘hotspots’.  In most technological SERS applications, 
many analyte molecules and nanoparticles are measured simultaneously, because 
the spot size of the interrogating laser is many orders of magnitude larger than 
the nanoparticles or analytes.  Because of the extraordinary enhancement value 
of ‘hotspots’ they will dominate any spectra. 
SERS enhancement of Raman spectra is very good for pure analytes. 
However, many analytes co-exist with other interfering substances in complex 
matrices.  This is particularly true when examining biological analytes, which are 
often found in very complex biological matrices.  Biological fluids often contain 
multiple compounds that can bind to the metal surface, causing chemical 
enhancement and resulting in complicated and confusing spectra.  Even when 
they cannot bind to the surface, all analytes within the effective range for 
electromagnetic enhancement will contribute to the Raman spectrum and may 
deliver interfering fluorescence emission that will also complicate the spectra.  
These limitations have led to further modification of the technique. 
 
1.1.4 Functionalised- Surface Enhanced Raman spectroscopy 
The restrictions in SERS selectivity has led to several improvements on the 
SERS method of Raman spectroscopy enhancement, including shell isolated 
nanoparticles and Raman reporters.  These improvements are often combined in 
the same nanoparticles structure.   
Shell isolated nanoparticles are metallic nanoparticles that have been 
coated with an inert outer shell. The outer shell can be polymer based [13] or 
silica and prevents non-specific binding to the nanoparticle surface [14]. The 
outer shell can then be functionalized with molecules with a specific affinity for 
the target analyte.   
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 Raman reporters are dye molecules that can be attached to the metal 
surface of shell isolated nanoparticles [15, 16].  Raman Reporters demonstrate a 
very strong Raman signal, and the enhancement is maximised by binding the 
reporter to the metal surface. The technique can be referred to as indirect SERS 
detection when Raman reporters are used, as binding of the analyte is assumed 
rather than directly observed.  Thus the analyte is indirectly detected through the 
detection of the Raman reporter molecule [17].  This represents a significant 
disadvantage, as the spectrum being acquired is not of the analyte itself, but of 
the Raman reporter molecule.  Consequently, the Raman reporter approach has 
very little value for the SERS screening of analytes, unless it is coupled with 
another method to ensure that the analyte is bound.  A ‘sandwich’ based method 
is common for this purpose, in which the analyte is anchored to the nanoparticle 
with one antibody and a second antibody that recognises a different epitope is 
used for detection. [fig. 1.1.3] 
Figure 1.1.3 Common setup for indirect sandwich style Raman. Note: the 1st antibody (1 AB) 
could be attached directly to the substrate, or to an unanchored nanoparticle.  
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1.1.5 Other Methods Currently Used for Detection of Biological 
Analytes, Their Advantages and Problems 
Several different techniques are currently available to detect biological 
analytes in solution.  For proteins, biochemists traditionally use the antibody 
based techniques like the Western blot or the enzyme-linked immunosorbent 
assay (ELISA) [18-22]. For nucleic acids, techniques such as Southern blot and 
polymerase chain reaction (PCR) based techniques can be used [18, 23]. The 
detection mode in these methods is usually colorimetric [20-22, 24], fluorescent 
[25-27], or radioactive.  
The SERS techniques typically require much smaller quantities of analyte, less 
time to complete the analysis, and reach lower detection limits than the currently 
used techniques for the analysis of biomolecules.  The sensitivity and rapidity of 
SERS techniques are particularly evident when compared with conventional 
ELISA. See table 1.1.1. A direct comparison of SERS detection techniques with an 
equivalent ELISA detection method found that the SERS technique increased the 
sensitivity by 5 to 6 orders of magnitude with a wider detectable concentration 
range, used lower reagent consumption, and required a shorter induction time 
[22].   
The SERS techniques in table 1.1.1 all employed a Raman tag, i.e. indirect 
SERS.  The direct SERS technique proposed in this study will retain all the 
benefits of these techniques, but will, in addition, directly confirm analyte binding 
and will collect information about the analyte within the SERS spectrum.  This 
additional information will allow discrimination between very similar molecules, 
even when antibody cross-reactivity is present. 
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Table 1.1.1 Analysis of the Strengths and Weaknesses of the Current Techniques, and Proposed 
New Techniques 
Method 
separation/ 
purification/ 
amplification 
detection 
time 
required 
sample 
sample 
size 
Lower limit of 
detection Ref 
 
M 
current methods 
ELIZA 
immuno 
sandwich 
colorimetric 16 hr 
human IgG & 
rabbit IgG 
10 μL 
10 ng/mL, 
25 ng/mL  
[22] 
ELIZA 
immuno 
sandwich 
colorimetric 14 hr 
antibodies to 
malachite green 
(raman tag) 
100μL 20 μg/mL 
 
[20] 
ELIZA 
immuno 
sandwich 
colorimetric ~5hr 
(fluoro) 
quinolone anti-
biotics in food 
5g 
4 -200 
μg/kg  
[21] 
flow injection flow injection 
Chemilumin-
escence 
30 sec 
Levofloxacin 
antibiotic in 
urine or serum 
500 μL 0.3 ng/ml 
 
[28] 
Capillary 
Electrophoresis 
hydroxyl 
propyl-β-
cyclodextrin 
fluorescence 3 min 
Levofloxacin 
antibiotic in PBS 
or urine 
- 
 
10 x10-9 in 
PBS 
[25] 
reversed-phase 
HPLC 
Organic 
extraction, 
chiral mobile 
phase  
UV >30 min 
Levofloxacin 
antibiotic in 
urine or serum 
plasma 
250 μL, 
urine 10 
μL) 
0.08 - 23 
μg/mL 
(plasma, 
urine) 
 
[29] 
Other suggested methods 
exonuclease 
protection 
assay 
aptamer with 
EPA Real-Time 
PCR 
fluorescence 4 hours thrombin(aq) 1μL 
~102 
mole-
cules 
 
1.7 x 10-16 [26] 
Aptamer DNA 
Arrays 
Aptamer 
imbedded 
array 
Confocal 
fluorescence 
microscopy 
2-3 min. 
thrombin(aq) and 
 in BSA 
100 μL 
 
2 x10-10 [27] 
Electrochemical 
Assay  
Aptamer with 
magnetic 
separation 
Electro-
chemical 
minimum  
1 hour 
thrombin  
in buffer, 
serum & plasma 
450 μL 
 
0.5 x10-9 
(buffer),  
<5 x10-9 
(bio-fluids) 
[30] 
circulating-flow 
piezoelectric 
biosensor 
Au nano-
particle PCR 
amplification 
piezo-  
electric 
varied 
>2.5 hr 
E coli in PBS, 
apple juice, 
milk, beef 
1mL,     
1 g beef 
1.2 × 102 
CFU/mL  
[23] 
Proposed Raman tagged SERS methods 
Raman tagged 
SERS 
Az–p53 
complexing 
Raman tag 5 hr 
wild-type and 
mutant p53 
proteins in serum 
200 μL 
 
500 fM,    
5 pM in 
serum 
[19] 
Raman tagged 
SERS 
Aptamer with 
magnetic 
separation 
Raman tag 1.5 hr 
thrombin in 
buffer,spiked 1% 
fetal bovine 
serum(FBS) 
25 μL 
 
0.27 pM [31] 
Raman tagged 
SERS 
immuno 
sandwich 
Raman tag 4 hr 
antibodies to 
malachite green 
(raman tag) 
100μL 50 pg/ml 
 
[20] 
Raman tagged 
SERS 
immuno with 
magnetic 
separation 
Raman tag 1 hr 
Viruses 
 in PBS 
50μL 
5 fg/mL - 
[17] 
25 pg/mL - 
Raman tagged 
SERS on 
microarray chip 
immuno 
sandwich 
Raman tag 1:45 hr 
human IgG & 
rabbit IgG 
0.75 μL 
10 fg/mL, 
10–100 
fg/mL 
 
[22] 
Raman tagged 
SERS with 
complimentary 
DNA 
sandwich to 
glass slide, 
DNA extracted 
from sample 
Raman tag 
1hr + 
DNA 
extract-
ion time 
genetically 
modified  
rice 
- 0.1 pg/mL  [18] 
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1.2  AIMS OF THE PRESENT STUDY 
The overarching aim of my thesis is to develop a technique capable of 
detecting ultra trace levels of biologically relevant molecules in biological fluids 
and/or aqueous solutions.  This technique should be able to: 
 Provide sufficient information about the molecule to adequately identify 
it. 
 Distinguish between very similar molecules. 
 Be impervious to water to simplify the method. 
 Measure ultralow quantities of analyte. 
 Carry out rapid on-site screening. 
However it should not: 
 Exhibit non-specific cross-reactivity. 
 Mask and/or swamp the analyte spectrum. 
Raman spectroscopy with its characteristic features is competent for the 
required detection. Functionalised metallic nanoparticles allow for the rapid SERS 
screening of ultra trace amounts of analytes in various aqueous matrices.  
However, the indirect detection method described above has important 
limitations. Direct SERS detection of analytes by functionalized nanoparticles is 
preferred, as it ensures that the method is actually detecting the analyte not just 
implying its presence.   
Critical innovations to the nanoparticle structure are required to enable the 
direct detection of analytes.  This research presents the development of 
functionalized nanoparticles with the desired features for the detection of ultra 
trace amounts of caffeine and erythropoietin (EPO) in aqueous and biological 
matrices by SERS.   
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1.3 WHAT WILL BE ATTEMPTED AND RESEARCH QUESTIONS 
ANSWERED  
In this study we developed a proof of concept for the direct, ultra trace 
detection of biologically relevant molecules in solution, using SERS detection of 
antibody functionalised nanoparticles.  This was developed using two model 
analytes: caffeine in caffeinated beverages and erythropoietin (EPO) in human 
urine.  Here we demonstrate that the technique is applicable to a wide range of 
biologically relevant molecules, from small organic biomolecules to much larger 
and far more complicated proteins.  
The questions that are answered in this proof of concept include: 
 Does the technique detect the analyte? 
 Will the nanoparticle manufacturing process interfere with the 
antibody’s reaction site? 
 Is blocking needed to prevent non-specific cross reaction?  
 What is the optimal nanoparticle reaction time for best analytical 
results?   
 Is the technique sufficiently sensitive for the desired application? 
 Can the technique distinguish between closely related analytes that 
might cross react with the functionalised nanoparticles?  
 Can the technique quantitatively determine the concentration of the 
analyte that is present?     
1.4 SIGNIFICANCE AND SCOPE OF THE RESEARCH 
The ultra trace detection of both small and large organic biomolecules is 
sought for many different applications.  While inductively coupled plasma mass 
spectrometry (ICP MS) is capable of trace detection of metal ions to a detection 
limit as low as 1×10-5 ng/g, but varying widely between minerals [32], few 
methods are capable of trace or ultra trace detection of organic molecules.  ICP 
MS is only useful for organic molecules where the molecule is organometallic.  A 
technique that is capable of ultra trace detection is urgently needed. 
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Biological molecules are frequently found in aqueous solutions.  When the 
analyte is in trace concentration, it is commonly found in a complex matrix with 
many possible interfering species.  Often extensive pre-analysis separation and/or 
concentration techniques are required to enable detection or to prevent false 
identification.  This increases the complexity of the analysis and the amount of 
time required.  A technique that allows direct measurement in biological fluids 
without this pre-preparation would be a valuable advance. 
One important example application where this technology could be used is 
for medical diagnostics and anti-doping purposes.  Many biomarkers for disease 
detection and monitoring are found in ultra trace levels within complex biological 
fluid matrices.  Detection of doping in sport often has the same limitations as 
medical diagnostics.  
The anti-doping effort often requires techniques that are capable of 
measuring ultra trace concentrations of doping agents or their metabolites.  
These doping agents are often found in biological fluids, and noninvasively 
obtained biological fluids, such as urine or saliva, are preferred. 
 Other examples of where technique could potentially assist include 
environmental monitoring of water for public health and homeland security; 
industrial/manufacturing processes where the determination of a particular 
analytes concentration in a mixture is required for quality control; and forensic 
applications where detection of trace level contaminants at a crime scene is 
sometimes required.  In fact, the scope of this technique’s applicability is only 
limited by the user’s imagination. 
TWO independent but related studies were used in this project.  An initial 
study using caffeine as the analyte was used to establish and troubleshoot the 
technique, followed by the main study, which analysed erythropoietin.  The 
corresponding chapters will provide the background specific to that particular 
study.  They will also present the results and discussion of the individual studies 
performed.  The following outlines the specific details of the remaining chapters: 
 A Novel Identification Method for Ultra trace detection of biomolecules                      15                                                    
Chapter 2 describes the experimental design. This chapter details the 
materials and instruments used for general nanoparticle manufacture and 
characterisation.  
Chapter 3 presents the results and discussion for the caffeine model 
analyses, including the characterisation of the caffeine specific nanoparticles and 
the initial studies to develop the general technique. 
Chapter 4 provides a background literature review of erythropoietin (EPO), 
recombinant human EPO (rHuEPO) and its misuse by athletes, and the current 
techniques used to detect this misuse.  It then provides the results and 
discussion and summary for the EPO model analyses. 
Chapter 5 provides an overall summary of this work and indicates the 
future directions of the research. 
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Chapter 2: Materials and Methods 
This chapter describes the experimental design and procedures used to 
achieve the aims and process objectives stated in Section 2 of Chapter 1: to 
develop appropriately featured functionalized nanoparticles enabling detection 
and distinction of biologically relevant molecules at ultra trace levels in biological 
fluids.  This chapter discusses the materials used in the study; the instruments 
used for analysis; nanoparticle manufacture and characterisation; Raman 
spectroscopy and the data analysis.  
2.1 MATERIALS  
Caffeine standard (≤100%) and Gold III Chloride (AuHCl4) (99.9985%) 
were purchased from ProSciTech.  Trisodium Citrate (99%) ACS grade; Silver 
Nitrate (≥99.5%) (AT) Puriss p.a. Grade; (3-aminopropyl)-trimethoxysilane 
(APTMS) (97 %); Sodium Silicate (27%) Reagent Grade; 3-(trihydroxysilyl) propyl 
methylphosphonate (THPMP) 50 wt.% in H2O; and Glutaraldehyde (25 wt.%) 
grade I premium and Ethylamine (~70wt.%) were purchased from Sigma-Aldrich.  
For erythropoietin, the lyophilized World Health Organisation (WHO) 
human urinary reference erythropoietin standard (HUEPO, 2nd International 
Reference Preparation), containing 10 international units of purified human 
urinary HUEPO and the lyophilized WHO recombinant erythropoietin standard 
(rHuEPO, 3rd International Reference Preparation) containing 1650 international 
units (11 µg) of Epoetin α, were sourced from the National Institute for Biological 
Standards and Control, UK.   
Mouse monoclonal anti-Caffeine antibody (ab15221), manufactured by 
abcam, was purchased from Sapphire BioScience Pty. Ltd. Mouse monoclonal 
antibody anti-Erythropoietin antibody (3F6, 5.7 mg/mL) was purchased from 
MAIIA Diagnostics, Uppsala, Sweden. The 3F6 antibody recognises endogenous 
EPO as well as recombinant epoetins α, β, δ, Ω, and darbepoetin.  
Beverages containing caffeine (regular coke and diet coke from Coca Cola 
Company and a short black from a barista) were purchased and analysed using 
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the developed SERS nanoparticle method for their caffeine content. Caffeine-Free 
diet coke (a caffeine free beverage from Coca Cola Company) was also analysed 
for comparison purposes.  
Self-donated urine was analysed for human erythropoietin content by the 
developed SERS nanoparticle method. The use of self-donated human urine 
complies with QUT ethical regulations.  
2.2 INSTRUMENTATION 
Eppendorf Microcentrifuge (model 5430) (1.5 mL tubes), and Bransonic 
Ultrasonic Cleaner (model 1510E – MTH) from Branson Ultrasonics Corp were 
used for the separation and re-dispersion of the prepared nanoparticles during 
synthesis and following binding to the respective target analytes. 
UV-VIS Spectrometer: 
The Cary 100 spectrometer (Agilent Technologies, USA) was used for UV-
Vis characterisation of the nanoparticles. 
Transmission Electron Microscope: 
The nanoparticles where characterised using the JEOL JEM-2100F TEM 
(JEOL, USA).   
  Raman Spectrometer:   
A Renishaw inVia Raman Microscope, with microscope spot size 1 µm and 
excitation wavelength of 785nm was used for the Surface-Enhanced Raman 
Spectroscopy (SERS) measurements.  
2.3 NANOPARTICLE MANUFACTURE 
2.3.1 Bare gold nanoparticle 
Bare gold nanoparticles were initially manufactured using the traditional 
Turkevich method [33].  Briefly, 20 mL of 1 mM AuHCl4(aq) was heated to boiling 
with vigorous magnetic stirring in a beaker covered with a watch glass to 
minimise evaporation.  Two mL of warmed 1 wt% trisodium citrate(aq) was added 
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to the boiling AuHCl4 solution. During the course of the reaction, the colour 
changed from colourless to black, then purple, then to a clear red with a slight 
blue tinge.  The mixture was heated for about 5 min, until colour change was 
complete.   
In subsequent gold nanoparticle manufacture, the Turkevich synthesis 
method was replaced with the method reported by Xia et al [34].  This method 
was used to control the spherical shape of the gold nanoparticles. For the 
synthesis of the nanoparticles by the Xia method, a saltwater (NaCl) bath was 
heated with magnetic stirring until it commenced to boil.  Twenty mL of distilled 
water was placed in a two-neck round bottom flask fitted with a reflux condenser 
and heated in the saltwater bath to 95°C with rapid magnetic stirring.  AuHCl4(aq) 
(14.73 wt.%, 117.8 µL) and 17 µL of 0.1 wt.% AgNO3(aq) were mixed at room 
temperature with magnetic stirring.  Two mL of 1 wt.% trisodium citrate(aq) was 
added to the AuHCl4 mixture and stirred for 3 min.  The aqueous AuHCl4 mixture 
was then quickly added to the heated water and stirred for five minutes after the 
solution colour change was complete. The colour changes were from colourless to 
black, then to purple almost instantaneously.  The mixture then turned to a 
transparent red within 10 sec.  The solution was allowed to cool to room 
temperature. (Note: all concentrations designated wt.% were mass reagent in 
total mass of solution (i.e. wt/wt)) 
The trace amount of silver nitrate (8.5 x 10-5 wt.%) was added to increase 
the rate of oxidation of trisodium citrate to sodium acetone dicarboxylate (SADC), 
which increased the rate of nucleation and narrowed the nanoparticle size 
distribution.  Silver ions also encourage more spherically shaped nanoparticles by 
slowing the rate of gold deposition on particular polycrystalline facets that would 
otherwise lead to irregularly shaped nanoparticles. The trisodium citrate, AuHCl4 
and AgNO3 solutions were added and mixed at room temperature for several 
minutes to minimise the pH buffering effect of the citrate ions and induce a more 
homogenous nucleation[34].  
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2.3.2 Silica coating 
For the addition of a pacifying silica coat onto the gold nanoparticles, the 
reagents described by Liz-Marzán et al [35] and methods described by Li et al 
[36] were used. Briefly, the gold nanoparticle solution produced in section 2.3.1 
was mixed with 131.25 µL of 1 mM APTMS under vigorous magnetic stirring for 
15 min. Eighty four µL of activated sodium silicate(aq)  (0.54 %(v/v)) was added. 
The pH of the solution was lowered to 10-11 using 1M HCl). The solution was 
rapidly heated to 90°C in a saltwater bath and vigorously stirred for 20 min.  It 
was then allowed to cool to room temperature.  The silica coated nanoparticles 
were centrifuged (25 minutes) and the supernatant was removed.  Centrifugation 
(at this stage and hereafter) was done at maximum speed for the instrument.  
The silica-coated nanoparticles were then washed by resuspending in an equal 
amount of ethanol under sonication, followed by centrifugation. This process was 
repeated twice more.  After the final wash, the supernatant was removed and the 
nanoparticles were allowed to evaporate to dryness. 
 
2.3.3 Functionalization of the silica-coated nanoparticles with 
antibodies 
The nanoparticles were functionalised with the appropriate antibodies 
according to the method described by Freitag et al [37] with a slight modification 
of the buffer and blocking agent used at the final step. The process consisted of 
the following steps: 
 
A-Priming the nanoparticle 
The silica-coated nanoparticles were re-suspended in distilled water.  They 
were concentrated during the re-suspension process from 24 x 1.5 mL centrifuge 
tubes by re-suspending 8 tubes at a time, then transferring resuspended 
nanoparticles to the next set of 8 and repeating this for the final 8 tubes.  The 
resuspended nanoparticles were then transferred to a flask.  The emptied 
centrifuge tubes were washed with a further 2 aliquots of 1 mL deionised water 
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and the washings were added to the flask for a total of 14 mL of nanoparticle 
solution. 
THPMP (5 % (v/v), 1.68 mL) was added and mixed under vigorous 
magnetic stirring for one hour at room temperature. The nanoparticles were then 
centrifuged (20 minutes), washed and evaporated to dryness.  (Twelve tubes) 
 
B-Adding pre-linker 
The THPMP-primed nanoparticles were resuspended in distilled water and 
concentrated by resuspending 4 tubes at a time to make a total of 8 mL of 
primed nanoparticle solution.  Eight mL of 1 mM APTMS solution (pH 5-6, 
acidified with CH3COOH) was added and mixed under vigorous magnetic stirring 
for 30 min at 35° C. The nanoparticles were then centrifuged (20 minutes), 
washed with Phosphate Buffered Saline (PBS, pH 7.4) and evaporated to dryness. 
(Ten tubes) 
 
C-Adding Glutaraldehyde linker  
The pre-linked nanoparticles were re-suspended in glutaraldehyde 
solution, 10% (v/v) concentrated then sonicated for 30 minutes. The 
nanoparticles were then centrifuged (15 minutes) and washed with PBS (pH 7.4) 
and evaporated to dryness. 
 
D-Immobilization of antibody and blocking of un-reacted 
glutaraldehyde linker 
The appropriate antibody was diluted with PBS, giving 3 x 1.5 mL tubes 
(caffeine antibody, 1:200) and 4 x 1.5 mL tubes (EPO antibody, 1:300). One tube 
of the glutaraldehyde-functionalised nanoparticles was re-suspended in an aliquot 
of the diluted antibody. The mixture was allowed to react at 4°C overnight. The 
nanoparticles were then centrifuged (10 minutes) and washed with PBS. The 
resultant antibody-functionalised nanoparticles were re-suspended in 1.5 mL of 
0.7 % (v/v) ethylamine solution (in PBS) by sonication. The solution was kept at 
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4°C for 30 min to allow the ethylamine to bond with any remaining aldehyde 
groups of the glutaraldehyde linker. The blocked nanoparticles were then 
centrifuged and washed with PBS. 
2.4 NANOPARTICLE CHARACTERISATION 
The nanoparticles were characterised by UV-Vis spectroscopy to determine 
their plasmonic properties.  Transmission Electron Microscopy (TEM) was used to 
determine the size and shape of the gold nanoparticles (before and after the 
coating procedures and immobilization of the antibodies) as well as the thickness 
of the silica coat.   
For the TEM technique, 1:10 dilutions of the nanoparticles were used for 
each type, except for the complete antibody-functionalized nanoparticles, which 
were analysed undiluted.  To load the sample onto the TEM grid, a drop of the 
diluted nanoparticle sample was dropped on a Cu grid, coated with carbon, 
allowed to set for 3 min.  The surplus fluid was removed by absorption onto filter 
paper. If the coating was subsequently found to contain insufficient nanoparticles 
for analysis, the loading process was repeated for a further 5 min. 
 
2.5 RAMAN SPECTROSCOPY 
The completed antibody-functionalized gold nanoparticles were directly 
analysed by Raman spectroscopy without dilution to acquire a background SERS 
spectrum of the nanoparticles prior to their interaction with the target analyte. 
For the detection of the target analytes in standard solutions by SERS, the 
appropriate antibody-functionalized nanoparticles were mixed 1:1 with the target 
analyte solution to produce a 20 μL sample and spun down with brief 
centrifugation to ensure that the sample and nanoparticle were mixed.   After 
mixing, the solution was allowed to react for the predetermined optimal time for 
each antibody, loaded on a glass microscope slide, covered with aluminium foil, 
and then air dried.  
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 The above procedure was repeated for caffeinated beverages and urine. 
The samples were then washed (by several replications of centrifugation, removal 
of supernatant and resuspension) to remove the unbound proteins and other 
interfering molecules that may produce interference fluorescence during the 
SERS measurements.  As loss of nanoparticles may occur during the washing 
process, 60 µL total volumes were used to compensate, and the nanoparticles 
were resuspended in 20 µL of PBS before transfer to the slides.  
Since human urine has a wide pH range, PBS was used as a buffer to 
regulate the urine medium to pH 7.4 to ensure the stability of the bond between 
the glutaraldehyde linker and the antibodies [38].   
The Raman spectroscopy measurements were carried out using excitation 
laser at 785 nm, at 5% of maximum (450 mW) laser power, i.e. 22.5 mW.  
Unless otherwise indicated, spectra were collected within the spectral region 350 
cm-1 to 1700 cm-1.  All spectra were obtained using a 10 second exposure time. 
The initial caffeine experiment used a single accumulation, while subsequent 
experiments acquired 10 accumulations per sample measurement.  A minimum of 
6 measurements per sample was carried out for all Raman measurements.  
 
2.6 DATA ANALYSIS  
2.6.1 Collection, Pre-treatment and Initial examination of results 
The spectral data for each sample were collected and data pre-treatment 
was carried in Microsoft Excel 2007 as described below.  
The data points for each spectrum were baseline corrected, by subtracting 
the intensity of the lowest point of the spectra between 350 cm-1 and 1600 cm-1 
from each data point.  They were then normalized according to a published 
method [39]. The formula for these transformations for the ith spectral point 
(where hi is the peak intensity for the ith peak and 100 is an arbitrary scaling 
factor for ease of handling and display) is as follows: 
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An Excel spread sheet was designed to collect the results for the initial 
analysis, the major peaks of the analyte’s reaction with its antibody, as well as 
the hierarchical PCA (HPCA) data.  The data were then used in the relevant 
chemometrics analysis. 
Preliminary examination of individual spectra and averages of the 6 
spectral replicates of analytic samples was performed by visual inspection to 
detect any obvious trends in the data.  Excel 2007 was used for this analysis. 
 
2.6.2 Quantitative analysis  
The r2 value for each of the major peaks of the analyte verses the analyte 
concentration was calculated using the RSQ function in Excel 2007. Excel’s RSQ 
function returns the square of r (the Pearson product moment correlation 
coefficient) where r is defined as: 
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The major peaks with the highest r2 value (i.e. ≥ 0. 7) were chosen for 
each analysis.  High values of r2 suggested that the spectra of the samples at 
that wavelength correlated best with the concentration of the analyte in the 
samples.  Linear or logarithmic calibration curves were constructed to determine 
which gave the best r2 value. 
 
2.6.3 Chemometrics analysis  
The software used for the Chemometrics analyses was SIMCA P+ 13 from 
Umetrics AB, Sweden.   
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Principal component analysis (PCA)  
PCA was performed using all of the major peaks.  The PCA model was 
refined by identifying the outliers and/or peaks that were poor predictors as 
identified in the software’s built-in functions. 
 
Hierarchical PCA (HPCA) 
For the HPCA model, the spectra were divided into 10 to 14 approximately 
evenly sized blocks encompassing the spectral regions of interest.  For example, 
the interference studies were performed using the regions known to vary with the 
analyte concentration, while ignoring those spectral regions known to be 
associated with the background nanoparticle. PCA was performed on each block 
and a maximum of 3 significant PCs were recorded. The significant PCs from the 
initial PCA were used as the variables to perform a subsequent PCA, i.e. the 
HPCA.  
 
Partial Least Squares (PLS) using Major Peaks 
The data was divided into training and test sets.  Preliminary PCA was 
performed on the data, using the wavenumber values of the major peaks as x 
values. The values of the major peaks are indicated in section 2.6.4. For the PLS 
analysis, the concentrations of the standard solutions were used as the y 
variable.  Successive models were executed with various combinations of the x 
variables to identify the combination with the highest R this 2 values, lowest Root 
Mean Square Error of Estimation (training set), and Prediction (test set) [RMSEE 
and RMSEP] values.   
 
2.7 STUDIES PERFORMED 
2.7.1 Unreacted nanoparticle and concentrated analyte 
An initial study for the analyte and its unreacted nanoparticle was 
performed to identify the major Raman peaks, and to distinguish between major 
Raman peaks that were related to the unreacted nanoparticle and those that 
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were related to the reaction of the analyte with the antibody.  In all studies, 
visual inspection was performed using the averaged pre-processed spectra.  A 
previously optimised reaction time of 30 minutes was used. 
2.7.2 Effect of time on the binding between the analyte and the 
antibody-functionalized gold nanoparticles  
The optimal reaction time for the binding reaction between the analyte 
and the antibody-functionalized gold nanoparticles was determined empirically.  A 
standard solution of the analyte, caffeine (1x10-6 M) and EPO (1x10-8 M), 
respectively, was mixed with the relevant antibody-functionalized gold 
nanoparticles and the solution was incubated for a series of times, spanning 5 to 
60 minutes for caffeine and 0 to 600 minutes for EPO (where 0 minutes = air 
drying immediately after mixing). These samples were then analysed by SERS.   
The spectra were overlaid and the major peaks were visually inspected to 
determine the time point beyond which there was no further significant change in 
signal intensity with increasing time.  This optimal reaction time, determined to 
be approximately 10 minutes for caffeine and 30 minutes for EPO, was then used 
for all further studies with the respective analyte.  
 
2.7.3 Development of calibration curves for the quantifications of the 
target analytes  
To develop a calibration curve for each analyte, standard solutions of the 
target analytes (caffeine (10-4 M - 10-10 M), EPO (2x10-10 M - 10-15 M) were 
reacted with the relevant antibody-functionalized gold nanoparticles for the 
nominated optimum reaction time (10 minutes for caffeine and 30 minutes for 
EPO). The solutions were then screened by SERS, and the acquired spectra were 
analysed as indicated in section 2.6.4. If there were multiple peaks that fulfilled 
the criteria outlined (RSQ ≥ 70%) PLS (as in section 2.6.5) was attempted to 
determine if this would give a better R2 result than univariate regression.  
 Calibration curves for caffeine and EPO were constructed by plotting the 
normalized signal intensity against the concentration of the analyte on a log 
scale.  
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2.7.4 Interference study  
Initial study EPO vs. rHuEPO only 
The initial EPO interference study was performed using the 2nd 
international reference standard for human urinary EPO (HUEPO) and the 3rd 
international reference standard for rHuEPO.  1x10-13 M solutions of the 
international reference standards were prepared, reacted with the relevant 
antibody-functionalized gold nanoparticles and screened using SERS, and the 
acquired spectra were inspected visually and a PCA of the relevant major Peaks 
was performed to determine whether there was any significant interference. 
 
Interference study using real-life samples 
The interference study was performed/ repeated using the relevant 
beverages/ biological fluid containing the analyte. For the EPO model, spiked 
biological fluids were also used. The spiking was done by mixing, 1:1, the 
biological sample and standard solutions (HUEPO IS and rHuEPO IS, at 1X10-12 M 
and 1x10-14 M).  The samples were then reacted with the relevant antibody-
functionalized gold nanoparticles and washed (as described in section 2.5) to 
remove the unreacted/interfering substances (e.g. proteins from the matrix of the 
biological sample).   
The washed nanoparticles were then screened by SERS as described in 
section 2.5. After visual inspection of the spectra, PCA models of the relevant 
major Peaks / HPCA analyses were developed as described in section 2.6.5 to 
determine whether there was any relevant interference with endogenous 
components or cross reactivity. The specific comparisons for the caffeinated 
beverages and EPO are described in chapters 3 and 4 respectively.  
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2.7.5 Reactivity of antibody before and after immobilization onto the 
gold nanoparticles nanoparticle (Caffeine model only) 
To determine whether the immobilization of the antibody onto the gold 
nanoparticles would result in blocking of the antibody binding sites and 
potentially destroy its reactivity towards the target analyte, a standard solution of 
caffeine (1 x 10-6 M) was mixed with an aliquot of the caffeine antibody prior to 
linking the antibody to the nanoparticles.  A second aliquot of the caffeine 
standard solution was mixed with the antibody-functionalized gold nanoparticles 
solution, in the proportions outlined in section 2.6. The resulting mixtures were 
examined using SERS.  Visual inspection of the spectral data and PCA analysis of 
the relevant major peaks was performed as described in section 2.6.5. 
 
2.7.6 Confirmation of blocking adequacy 
The caffeine studies were initially performed with unblocked nanoparticles. 
When the cross-reaction potential was intimated in the beverage studies the 
nanoparticles were mixed with ethylamine to bind to any un-reacted linker 
aldehyde groups that might remain following immobilisation of the antibody to 
the nanoparticle.  Raman spectra of the un-blocked and blocked nanoparticles 
were then obtained and visually compared for variations that might indicate the 
blocking was inadequate.  Repeat experiments were performed after blocking, 
using PCA and HPCA (using the data from the entire spectra) to confirm the 
adequacy of the blocking step. 
Additional confirmation of the adequacy of blocking was performed with 
the EPO antibody attached nanoparticles using skim milk. 
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Chapter 3: Caffeine Model 
3.1 BACKGROUND 
Caffeine [fig. 3.1.1] is the world’s most widely used legal stimulant [40, 
41]. It stimulates both the cardiac muscle and the central nervous system, 
however, it may have negative effects on the gastrointestinal tract when 
consumed in large amounts. Caffeine can be found naturally in plants, where it 
serves as the plant’s natural insecticide [42]. Synthetic caffeine or extracts from 
caffeinated plants are found in numerous commercially produced beverages and 
in coffee, tea and various naturally caffeinated herbal teas [43, 44]. Caffeine is 
also present in an increasing number of pharmaceutical and medicinal herbal and 
“energy” products [40, 43].  
The inclusion of caffeine in a wide range of commercial products highlights 
the importance of developing cost-effective effective and facile methods for its 
rapid identification and quantification in food, supplement and pharmaceutical 
products [43, 45]. 
An interesting and important 
analytical application associated with 
naturally caffeinated plant products is 
provenance. With the increasing use 
and popularity of naturally 
caffeinated extracts in beverages, 
food and pharmaceuticals, there is 
the potential for falsification of the 
product by incorporating a cheaper 
and more available plant extract. This 
is suspected to be a concern with 
guarana extract containing products, due to their high popularity and the rare 
main source of this product.  Greater than 80% of guarana is traditionally hand 
produced by the Amazon based Guarani Indians [43]. 
Figure 3.1.1 Diagram of caffeine with atoms 
numbered. 
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Multiple analytical protocols are available for caffeine detection and 
quantification, with chromatography-based separation techniques dominating the 
reported methods [40, 43, 46-49]. Vibrational spectroscopy has also been 
employed using various Fourier transform infrared spectroscopy (FT-IR) based 
methods [50-52] and near infrared spectroscopy (NIR) [53]. Most of these 
techniques require complicated extraction methods and/or mobile phases utilizing 
organic solvents (e.g. chlorinated solvents, methanol, acetonitrile or chloroform 
[40, 43, 46-50, 52, 53]), which are toxic to humans and not environmentally 
friendly. The solvent extraction procedure is essential in most methods, because 
caffeine is poorly soluble in water, and highly purified extracts are required to 
detect trace amounts of the substance [40, 43, 49]. 
Various FT-Raman techniques have also been applied to caffeine 
detection, and complex extraction/ clean up procedures are again required. FT-
Raman analyses suffer from interference from other products that may co-exist 
with the target analyte in complex natural matrices (matrix effect) [43, 45]. 
However, Raman spectroscopy is still reported as a viable technique for 
identifying caffeine in caffeinated products [40, 43-45, 51]. Traditional solvent 
extraction techniques prior to Raman analysis failed to eliminate significant matrix 
effects with other molecules that were co-extracted with caffeine [43]. Solid-
phase extraction techniques minimised, but could not eliminate, organic solvents, 
which were required to remove the concentrated caffeine from solid-phase. This 
solid-phase extraction technique also achieved an improved lower limit of 
detection (LLOD) of 18.1 mgL-1 (9.3×10-5 M) [40].  
The present study employed surface-enhanced Raman spectroscopy 
(SERS), for caffeine detection. Our method employed an immuno-
separation/capturing technique to ensure the selective detection of caffeine 
against a complex matrix background without purification, and eliminates the 
requirement for organic solvents. This technique offers significant sensitivity 
enhancement relative to other techniques, which stems from the SERS well-
known ability to detect ultra-trace amounts of the target molecule, potentially 
down to the single molecule level [11, 12, 54, 55]. 
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The sensitive environmentally friendly technique developed here is non-
destructive and uses very small sample sizes without requiring a pre-purification 
step. While this technique could revolutionize caffeine analysis in food products, it 
could have much wider applicability for small molecule analysis and potentially 
analysis of much larger biomolecules. Here we present the SERS detection of 
caffeine as an application exemplar for a more general method to detect small 
molecules in solution. 
3.2 AIMS OF THIS STUDY 
In addition to the specialised interest in developing a rapid and sensitive 
method for the detection of caffeine as an important industrial substance that is 
involved in many commercial products, the caffeine analyte was selected to 
demonstrate proof-of-concept for an innovative surface enhancement Raman 
spectroscopy-based technique for the rapid, sensitive and selective detection of 
ultra-trace amounts of small molecules, such as drugs of abuse and illicit 
substances. It was chosen to determine the applicability of the proposed 
technique for detection and quantification of the small organic target analyte in 
complex matrices. 
3.3 DEVELOPMENT OF FUNCTIONALIZED GOLD NANOPARTICLE 
MANUFACTURE FOR CAFFEINE DETECTION 
Gold nanoparticles were synthesised by the traditional Turkevich method, 
the innovative method described by Xia, et al [34] and a modification of Xia’s 
method. See section 2.3.1 for a detailed description. Briefly, for the Xia 
technique, Millipore water was heated in a salt water bath under reflux. A mixture 
consisting of concentrated gold (III) solution, sodium citrate and trace amounts 
of silver nitrate was added. The silver nitrate was omitted in the modified Xia 
method. A video showing the progress of the modified preparation process is 
provided in appendix A.  
For the Turkevich method [33], dilute gold salt solution was heated under 
reflux and then the sodium citrate reducing agent was added to the reaction 
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mixture. The traditional Turkevich method was slightly modified to be performed 
under reflux to allow a more direct comparison between the three methods. 
3.3.1 Nanoparticle characterisation 
Visual Characterisation  
The colloidal nanoparticles that were produced by the three different reaction 
routes were very similar in colour [Fig. 3.3.1]. 
UV -Vis Characterisation 
The nanoparticles prepared by Xia’s method (and its modification) showed an 
absorption band at 517 nm in the UV-Vis spectrum, while those prepared by 
Turkevich method have a band at 522 nm [fig. 3.3.2]. The band width at 517 nm 
was 47.5 nm at half-height, while the band at 522 nm was broader with a width 
of 49 nm at half-height. These data imply that Xia’s method resulted in a narrow 
size distribution of the synthesized nanoparticles. This was attributed to the 
addition of silver nitrate to the reaction mixture [25].  
Figure 3.3.1 Photograph of Gold nanoparticles made by (L-R) 
the modified method with trace Ag, the modified method 
without trace Ag, and the traditional Turkevich method. 
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TEM Characterisation  
The TEM characterization of the nanoparticles indicated that those 
produced by the traditional Turkevich [33] citrate reduction method were poly 
dispersed, with respect to size and shape, when compared to those prepared by 
Xia’s method [figs. 3.3.3, 3.3.4].  
The visual, UV-Vis and TEM characterisations collectively indicated that the 
modified citrate reduction method using trace silver nitrate is effective in 
 producing more mono-diverse nanoparticles, both in spherical shape and in size. 
Therefore, Xia’s method was chosen for the preparation of the nanoparticles used 
in all of the SERS investigations of this study. 
Figure 3.3.2 UV-Vis spectrograph of the traditional Turkevich citrate reduction method for 
gold nanoparticle manufacture vs. the proposed citrate reduction method (Xia) and its 
modifications. Peak width at half peak height is shown for the 3 methods by the solid 
straight lines with the measurement noted beside. The wavelength of maximum peak 
height is straddling the dotted line indicating the positions. The colours corresponding to 
the key are used in all lines and labels. 
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3.4 CHARACTERISATION OF FUNCTIONALIZED NANOPARTICLES 
FOR CAFFEINE DETECTION  
After the bare gold nanoparticles were prepared, their surfaces were coated with 
a passive silica layer to protect the GNP from interacting non- specifically with  
interfering analytes and to provide the surface for immobilizing caffeine 
Figure 3.4.2 TEM of gold nanoparticles prepared by 
Xia’s method. 
 
Figure 3.3.1 TEM of gold nanoparticles prepared by the 
Turkevich method. Note: bar = 500nm 
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antibodies via silane chemistry. The procedures for silica coating and attachment 
of antibodies have been described in section 2.3 of this thesis. The nanoparticles 
used for the caffeine detection by SERS were characterised as described in 
section 2.4, with the exception that only the bare gold nanoparticles, the silica 
coated and functionalised gold nanoparticles were characterised. 
3.4.1 Visual Inspection 
The visual inspection of the nanoparticle colloid after the addition of the 
silica coat showed no change in colour. After the attachment of the caffeine 
antibodies to the silica coat, the colour of the nanoparticles colloid became black 
as indicated by figure 3.4.1   
Note: the functionalised nanoparticle colloids when concentrated are black 
due to the agglomeration of nanoparticles, but they appear grey in this 
photograph because they have been diluted more than the other colloids.  
Figure 3.4.3 Photograph of (L-R) the Bare Gold nanoparticles, 
the Silica coated nanoparticles, and the completed 
nanoparticles with Caffeine antibody attached. 
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 UV-Vis characterisation 
The UV-Vis spectroscopy showed that the bare and silica-coated Gold 
nanoparticles both showed an absorption band at approximately 530nm. There 
was no obvious absorption band for the nanoparticles after immobilization of the 
caffeine antibody attached to the silica surface [fig. 3.4.2], which suggests that 
there is a mixture of particle sizes with no one size dominating.  In addition, the 
large nanoparticle clusters may cause light scattering which would complicate the 
UV-Vis spectrum. 
Figure 3.4.4 UV-Vis spectroscopy of the bare gold nanoparticles, silica coated 
nanoparticles and the completed nanoparticles with the caffeine antibody 
attached. 
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3.4.2  TEM characterisation 
The bare Gold nanoparticles in figure 3.4.3 below, produced with trace 
silver nitrate in the Xia’s[34] method are approximately spherical in shape, and 
contain only a small size range of sizes. This is consistent with the method used 
to generate the nanoparticles and potentially leads to greater reproducibility. The 
more consistent the size and shape of the nanoparticles are, the higher the 
probability of batch to batch reproducibility.   
The TEM of the silica-coated gold nanoparticles is shown in figure 3.4.4. 
The silica coating method was chosen to produce a very thin coating 
(approximately 2 nm)[36]. As silica is a small molecule with low density, it is 
difficult to visualise in the TEM. However a slight increase of ~2 nm in the size of 
the nanoparticles was observed, relative to the bare gold nanoparticles [fig. 
3.4.3] on measuring the nanoparticles in their TEM while expanded in Microsoft 
Office Picture Manager.  
The TEM image of the antibody-coated gold nanoparticles following the 
caffeine antibody immobilization is shown in figure 3.4.5. The caffeine antibody-
functionalised gold nanoparticles were observed to form large aggregates of gray 
Figure 3.4.5 TEM of the bare gold nanoparticles produced by 
Xia’s method using trace silver nitrate. 
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Figure 3.4.7 TEM of silica coated nanoparticles 
 
Figure 3.4.6 TEM of completed nanoparticle with caffeine antibody 
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colour [fig. 3.4.1].  The large size of the nanoparticles contributes to the light 
scatterings properties of these aggregates. 
3.5 COMPARISON OF STANDARD RAMAN, SERS AND 
FUNCTIONALISED SERS SPECTRA OF CAFFEINE  
Firstly, a Raman measurement of caffeine was obtained at 1 × 10-3 M 
using the drop-dry technique for the loading of the sample onto the gold 
nanoparticles. In this technique, an aliquot of the analyte solution was loaded 
onto the surface of an aluminium foil covered slide and allowed to dry.  For the 
SERS method the nanoparticle solution was added and dried before adding the 
analyte solution to the deposited nanoparticles. The resulting 
analyte/nanoparticles mixture was then allowed to dry prior to the SERS 
measurements. Then SERS measurements of caffeine were collected at a series 
of concentrations from 1 × 10-3 M to 1×10-6 M on bare gold nanoparticles. This 
technique was also used for the SERS measurements of caffeine by the antibody-
coated nanoparticles in the concentration range of 1 × 10-4 M to 1×10-10 M.  
3.5.1 Raman spectra of caffeine  
The Raman spectrum of caffeine at 10-3 M is shown in figure 3.5.1 below. 
The caffeine Raman spectrum shows a very prominent band at 556 cm-1 and a 
less prominent one at 1325 cm-1. The band at 556 cm-1 is caused by the 
combination of the pyrimidine (six membered) ring breathing, in plane C14 - N7 - 
C deformation, CH bending, CH3 symmetrical bending and CH3 rocking [41]. The 
band at 1325 cm-1 is caused by the Imidazole trigonal ring  
stretching of the caffeine molecule [41]. Refer to the structure of caffeine in 
figure 3.1.1 above. 
  It is unlikely that 10-3 M of caffeine in solution could be detected by Raman 
spectroscopy, because of its inherent weak effect. Drying the solution before 
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Raman analysis allowed this detection by a phenomena known as the 
 
Figure 3.5.1 Raman spectra of 1 x 10-3 M Caffeine 
 
coffee ring effect [56]. When a coffee drop is allowed to dry, the coffee 
concentrates by capillary action into a dark ring around the edge of the drop. 
This phenomenon is not exclusive to coffee, and has many important effects 
[57].   
In our study, the small caffeine molecule was drawn to the edge of the ring, 
where it was concentrated and ultimately detected. This form of natural 
chromatography has been named nanochromatography [57]. Direct Raman 
measurement of a standard solution of caffeine at 1 × 10-4 M was also 
attempted, using the drop dry method as explained above. Considering the 
height of the peak at 556 cm-1, (fig. 3.5.1), some evidence of this could have 
been expected with a 1: 10 dilution, but its detection was unsuccessful as the 
white ring of pure caffeine was too faint to determine its position. Thus the lower 
limit of detection (LLOD) for caffeine by direct Raman spectroscopy was 
confirmed to be 1 x 10-3 M. 
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3.5.2 SERS spectra of caffeine using bare gold nanoparticle  
The ability to detect molecules with Raman spectroscopy can be 
significantly enhanced when the analytes are in contact with, or very close to, 
metal nanoparticles, particularly those of coinage metals (e.g. Ag and Au). Gold  
nanoparticles were prepared as described in section 3.4.1 [using Xia’s method], 
and were used for SERS detection of caffeine across a series of standard 
solutions in the concentration range 1×10-3 M, 1×10-5 M and 1×10-6 M. The 
results are shown in figure 3.5.2. For comparison the bare gold nanoparticle 
background spectrum is also shown.   
A prominent result was found for the 10-3 M and 10-5 M caffeine standards. The 
spectra in fig 3.5.2 were consistent with the reference spectrum of caffeine as 
shown in the literature [41].Although the averaged SERS spectrum of the 10-6 M 
caffeine solution showed caffeine- specific Raman bands, only one of the eight 
spectra taken showed any caffeine with the remainder showing no evidence of 
caffeine at all, therefore confident detection of caffeine was only possible down 
Figure 3.5.2 Stacked SERS Spectra of caffeine standards at 10-3 M, 10-5 M and 10-6 M and the 
bare gold nanoparticles for comparison. The gray boxes show the most prominent bands caffeine 
from the Raman spectra of caffeine. The 10-3 M and 10-5 M spectra have been raised and the 
background lowered for clarity. 
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to 10-5 M [fig. 3.5.2], which we defined as the LLOD for caffeine on our bare gold 
nanoparticles 
3.5.3  SERS spectra of caffeine with caffeine antibody functionalised 
gold nanoparticle 
The functionalization of the gold nanoparticles with analyte-specific 
binding molecules adds selectivity to the already ultrasensitive detection of the 
target analyte [58-60].  
Our antibody-functionalised nanoparticles were designed to specifically 
capture the caffeine molecule through the selective binding properties of the 
caffeine-specific antibody, while limiting or eliminating non-specific cross reaction 
with potentially interfering molecules. In addition, the thin silica passive shell 
around the gold surface of the nanoparticles prevents non-selective direct 
adsorption of interfering molecules onto the gold surface. Therefore, the 
antibody-functionalised nanoparticles immobilize and pre-concentrate the caffeine 
molecules close to the gold surface of the nanoparticles and enable the sensitive 
and selective SERS detection of caffeine [58-60].  
The reference SERS spectrum of antibody-functionalised gold nanoparticles 
that have not been exposed to caffeine shows prominent bands at 1000 cm-1 and 
1030 cm-1.  (See the nanoparticle background spectrum in Figure 3.5.3.)  These 
bands are characteristic of pyridine ring vibrational modes [61] and arise as a 
result of our method of cross-linking the antibody to the modified silica surface. 
The glutaraldehyde linker attachment to the modified silica surface involves the 
reaction between glutaraldehyde and the terminal amine groups of the silica 
shell. The reaction of glutaraldehyde with amines has been reported to result in 
some dimerization [62, 63], such as the formation of quaternary pyridinium 
compounds [38]. The formation of the pyridinium species would give rise to 
pyridine bands in the SERS spectra of the antibody-functionalized NPs. Therefore 
any caffeine-specific Raman bands that fall in this spectral region could not be 
confidently used for analysis. 
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A panel of standard caffeine solutions ranging from 1×10-4 M to 1×10-10 M 
was exposed to the antibody-functionalised nanoparticles. Figure 3.5.3 shows the 
SERS spectra of 1×10-4 M, 1×10-6 M and 1×10-9 M caffeine solutions after their 
interaction with the antibody-functionalized gold nanoparticles. 
 The caffeine-specific Raman bands at 560 cm-1 and 1300 cm-1, however, 
remain evident at concentrations as low as 1×10-9 M. (While there are peaks in 
these regions, at 1×10-9 M the peak at 1300 cm-1 remains higher than the 
background.) These peaks were chosen as they correspond to the most 
prominent peaks in the Raman spectrum of caffeine [fig. 3.5.1].  
The SERS spectra in figure 3.5.3 showed spectral differences compared to 
those obtained for caffeine by the bare gold nanoparticles [fig. 3.5.2]. The two 
characteristic caffeine Raman bands at 556 cm-1 and 1325 cm-1 in the Raman 
caffeine spectra [fig. 3.5.1] shifted to 560 cm-1 and 1300 cm-1, respectively. 
The specific causes of these shifts are unknown. The small shift from 556 
cm-1 to 560 cm-1 might be attributed to instrumental variation. Pavel et al 
Figure 3.5.3 Stacked SERS Spectra of caffeine standards at 10-3 M, 10-5 M and 10-6 M and the 
bare gold nanoparticles for comparison. The gray boxes show the most prominent bands caffeine 
from the Raman spectra of caffeine. The 10-3 M and 10-5 M spectra have been raised and the 
background lowered for clarity. 
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attribute the caffeine Raman band at 1325 cm-1 to the imidazole (five membered) 
trigonal ring stretching.  They report that that the shift of the band at 1325 cm-1 
inward to approximately 1311 cm-1 is pH dependant. This peak shifts at about pH 
6.5 and remains there at higher pH, see Table II and figure 2 in this reference 
[41]. We used buffering at pH 7.4 so this amount of shift is expected.  The 
background has a peak ~ 1298 cm-1. In figure 3.5.3, the peak at 1298 cm-1 
marginally shifts to 1302 cm-1 with increasing concentration. So, the peak at 1300 
cm-1 could be this caffeine peak at 1311 cm-1 superimposed on the background 
nanoparticle peak at 1298 cm-1.   
This spectral shift could also be partially due to the high affinity binding of 
caffeine to the antibody on the surface of the gold nanoparticles. Specific 
intermolecular interactions (e.g. hydrogen bonding) between the analyte moieties 
and the antibody could potentially shift the wavelengths of the analyte Raman 
bands. This ring’s nitrogen atom moiety (N 9) [fig. 3.1.1] carries a lone pair of 
electrons that is available for hydrogen bond donation as well as other potential 
interactions with the antibody [43]. Further characterisation will be required to 
fully understand this spectral shift. 
3.6 IS THERE INTERFERENCE WITH THE ANTIBODY’S ANTIGEN 
BINDING SITE WHEN LINKING THE NANOPARTICLE?  
  The caffeine antibodies were attached to the gold nanoparticles via a 
glutaraldehyde crosslinker, which reacts with primary amines [38]. In proteins, 
primary amines are found in the lysine side-chain and at the N-terminus of each 
peptide chain. The N-terminus of the each of the four antibody protein chains is 
located in the antigen binding sites. See figure 3.6.1 below [64]. If the antibody 
is attached to the nanoparticle through any of the primary amines within the 
antigen binding site there, steric hindrance might prevent the antibody from 
binding efficiently to the antigen. This would likely result in a significant 
difference in the Raman spectrum. 
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To determine whether the immobilization of antibodies on nanoparticles 
interferes with the ability of the antibody to react with the analyte, we compared 
the Raman spectra of caffeine solutions that were interacted with free caffeine 
antibodies prior to antibody immobilization (pre-bound) to spectra acquired by 
reacting caffeine solutions with antibody only after they had been immobilized on 
the gold nanoparticles (post-bound). Caffeine was also exposed to the antibody-
functionalized gold nanoparticles from different manufactured batches. The 
prepared solutions were analysed by SERS as described in section 2.5 of the 
Materials and Methods chapter. All data analyses and multivariate statistical 
treatments of the acquired spectra were performed as indicated in section 2.6.  
The results are reported in figure 3.6.2. These data compare the pre-
bound nanoparticles with post-bound nanoparticles and the data show that all of 
the post-bound samples were consistent within the model. About half of 
Figure 3.6.1 Schematic diagram of the basic units of an antibody (immunoglobulin) [61] 
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the pre-bound samples appeared to be different from the post-bound samples.  
The remaining pre-bound samples were statistically similar to the post-bound 
samples.  From these data, we can safely assume that no significant interference 
to antigen binding occurs as a result of immobilizing the antibodies on the 
nanoparticles.  
3.7 EFFECT OF TIME ON THE BINDING BETWEEN CAFFEINE AND 
ANTIBODY-FUNCTIONALIZED GOLD NANOPARTICLES  
To determine the optimal reaction time for the complete binding between 
the caffeine molecules and the antibody-functionalized gold nanoparticles, a 1 x 
10-6 M standard solution of caffeine was mixed with the antibody-functionalized 
gold nanoparticles and incubated under ambient temperature for different 
intervals of time (from five to 60 minutes). The incubated samples were then 
characterised by SERS as per the procedures in section 2.5. The caffeine-specific 
peaks at about 1300 cm-1 in the acquired spectra were used to determine the 
time at which no further appreciable changes in SERS signals intensities occurred. 
Figure 3.6.2 PCA of SERS spectra of caffeine solutions reacted with antibody-functionalized gold 
nanoparticles (light and dark blue diamonds) vs SERS spectra of caffeine solutions reacted with 
caffeine antibodies prior to immobilising on the nanoparticles (red triangles) 
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The results are shown in figure 3.7.1. The peak at 1300 cm-1 correlates with a 
prominent peak in the Raman spectra of caffeine (1325 cm-1), and it was baseline 
 separated.  
NOTE: this peak shifts wavelength as in figure 3.5.3 with increasing reaction time 
(i.e. analogous to increasing concentration). See figure 3.7.2A change between 5 
and 10min. The peak used for interrogation is indicated by the red arrows in 
figure 3.7.1, and figure 3.7.2 A. 
 The relationship between the peak intensity at 1300 cm-1 and the incubation time 
is shown in figure 3.7.2. The maxim intensity of the peak at 1300 cm-1 was 
observed after 10 minutes. Therefore, the optimal reaction time for the 
interaction between caffeine and the antibody-functionalized gold nanoparticles is 
10 minutes. This time was then used for the rest of the study. 
Figure 3.7.1 SERS measurements of caffeine (1x 10-6 M) at different time intervals. The 
caffeine solution was reacted with antibody-functionalized gold nanoparticles and incubated 
for different intervals of time (5, 10, 15, 30, 60 min respectively) prior to the SERS 
measurement. The red arrow indicates the monitored caffeine Raman band @ 1300 cm-1. 
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3.8 QUANTIFICATION OF CAFFEINE BY ANTIBODY-
FUNCTIONALIZED GOLD NANOPARTICLES  
In this part of the study we investigated the quantification of caffeine by 
SERS with the aid of the antibody-functionalized gold nanoparticles.  Standard 
solutions of caffeine in the concentration range 1×10-4 M to 1×10-10 M were 
prepared, interacted with antibody-functionalized gold nanoparticles and 
screened by SERS. The acquired spectra [fig. 3.8.1] were subjected to baseline 
subtraction and normalisation, see section 2.6.1.  
Figure 3.7.2 Relationship between caffeine signal intensity @ 1300 cm-1 and time A) 
Partial spectrum of 1×10-6 M caffeine reacted with nanoparticles (from 1200 - 1400 cm-1). 
The red arrow indicates location of indicative peaks for the reaction of the nanoparticle 
with caffeine, @ 1300 cm-1. B) Peak height @ 1300 cm-1 corresponding to vertical dotted 
lines in A (grey = 5min, black = 10 min) Note: improvement (and minor wavelength shift) 
from 5 – 10 minutes and relative consistency of both from 10 minutes to 60 minutes. 
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The signal intensity at 1300 cm-1 was found to be in excellent agreement 
with the ln function of the caffeine concentration in the  concentration range 
1×10-4 M to 1 ×10-10 M [fig. 3.8.2., 6 measurements were taken for each data 
point on the curve]. The regression line showed excellent linearity with R2= 
0.9794 [fig.3.8.2]. These results confirmed the quantification of caffeine by the 
prepared antibody- functionalized gold nanoparticles. 
 The average height of the nanoparticles background at this 
wavelength was measured individually as for figure 3.8.2.  Taking the LLOD as 
mean + 3*SD, LLOD of the caffeine that can be achieved by using our antibody-
functionalized gold nanoparticles was an intensity of 0.035 which is equivalent to 
5×10-11 M using the equation of the regression line, so conservatively we 
defined the LLOQ as 1×10-9 M. This LLOQ is five orders of magnitude lower than 
that achieved using the bare gold nanoparticles (without antibody attachment) for 
the SERS detection of the caffeine [fig. 3.8.2].   
Figure 3.8.1 SERS spectrum of caffeine using antibody-functionalised gold 
nanoparticles. The grey highlighted box indicates the peak caffeine Raman 
band, at 1300 cm-1, that was used for developing the calibration in figure 
3.8.2. 
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This improvement can be attributed in part to the immobilization and 
concentration of caffeine molecules close to the gold surface, which effectively 
increased the caffeine SERS signal intensity. This peak corresponds to a peak at 
1325 cm-1 in the SERS spectrum for caffeine on bare gold nanoparticles, see 
grey shaded box in figure 3.7.1. This SERS peak for caffeine has shifted in 
wavelength which is evidence that the caffeine is bound to its antibody with 
potential hydrogen bonding to N9 (Fig 3.1.1). The implications for calibration are 
that with hydrogen bonding to this atom the molecular vibration (Imidazole  
 trigonal ring stretching) that causes this peak would be inhibited /modified and 
the wavelength of the peak subsequently shifted. The second implication would 
be that the caffeine would be held as close as possible to the gold nanoparticles 
surface which would lead to maximum possible enhancement of this peak. 
Therefore this is an excellent choice as a peak for calibration purposes.  
 
Figure 3.8.2 Relationship between signal intensity at 1300 cm-1 and the 
concentration of caffeine solutions in the concentration range 1×10-4 M to 1 
×10-10 M (n=6). The trend line indicates the ln relationship between 
concentration of caffeine and the peak intensity at 1300 cm-1. Error bar = 1 
SD 
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3.9 STUDY OF INTERFERENCE ON THE DETECTION OF CAFFEINE 
BY ANTIBODY-FUNCTIONALIZED GOLD NANOPARTICLES  
A series of studies were performed to determine if other compounds that 
may co-exist with caffeine in beverages with complicated matrices can cause 
interference or completely compromise the detection of caffeine with the 
proposed method. As was mentioned in the Raman spectroscopy section, in this 
and subsequent studies washing was required to remove interfering large 
molecules prior to loading on the slide.  
In this study various beverages that contain caffeine were screened by 
SERS with the aid of the antibody-functionalized gold nanoparticles. After 
gathering the spectra, PCA of the relevant major Peaks or HPCA (as indicated) 
was performed as outlined in section 2.6.5 to determine if there was any relevant 
interference to the spectrum from other molecules present in the beverage. 
 
3.9.1 Coke vs Diet Coke™ 
Regular Coca-Cola™ and Diet Coke™ have similar content of caffeine. 
However, a major difference between the two products is the sweetener used in 
each. Coca-Cola contains sucrose, whereas Diet Coke uses aspartame as its 
sweetener. Aspartame is a molecule that contains a primary amine group. The 
Glutaraldehyde linker that is used in this study to attach the antibodies to the 
nanoparticles can react with primary amines. Therefore, any unreacted 
glutaraldehyde (not attached to an antibody molecule) can readily bind to the 
aspartame content in the diet coke beverage. This non-selective binding onto the 
surface of the antibody-functionalized gold nanoparticles may cause a significant 
interference to the caffeine spectrum.  
This study was performed to check if it was necessary to block any un-
reacted glutaraldehyde. The antibody-functionalized gold nanoparticles were 
originally designed without blocking molecules in order to keep their synthesis as 
simple as possible. However it was important to determine whether this was 
adequate for commercial products with complex matrices or if blocking of the un-
reacted glutaraldehyde molecules is necessary to prevent uncontrolled cross 
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reaction with unknown interfering compounds. The results are shown in figure 
3.9.1. 
Careful inspection of the spectra in figure 3.9.1 indicated minor differences 
between some of the corresponding peaks of the Coca-Cola™ and Diet Coke™ 
averaged spectra. Height differences that do not appear to be solely the result of 
background variability are also present and may be more significant to the 
difference between the two samples, particularly if there has been non-specific 
binding to the unreacted glutaraldehyde. 
To confirm whether these differences seen in the spectrum are significant, 
PCA analysis of the two samples was performed using the prominent positive 
peaks remaining after subtraction of the averaged background spectra from each 
individual spectrum before baseline correction and normalisation. The PCA 
analysis comprised two significant components: component 1 comprising 84.5% 
of the variation in the data, and component 2 comprising 6.9% of the variation in 
the data. The results are shown in figure 3.9.2.  
Figure 3.9.1 Spectra of regular Coca-Cola™ compared with Diet Coke™ reacted with the 
original unblocked antibody-functionalized nanoparticles [without background 
subtraction].  
52                     A Novel Identification Method for Ultra trace detection of biomolecules                            
The regular Coca-Cola™ and Diet Coke™ are clearly separated in this 
study. The major separating component is component 2 which comprises less 
than 10% of the variation. While on component 1, which has the majority of the 
variation, the two samples are largely overlapped. This is consistent with the 
graph in figure 3.9.1 as the differences between the two averaged sample graphs 
are minor. This study implied that there is binding between the aspartame and 
un-reacted glutaraldehyde molecules. Therefore, it was determined that, blocking 
of the unreacted glutaraldehyde is required to avoid any cross interaction with 
interfering molecules. We further investigated this conclusion by investigating the 
interaction between the unblocked antibody- functionalized gold nanoparticles 
and the caffeine-free Diet Coke™ beverage. 
 
Figure 3.9.2 PCA of regular Coca-Cola and Diet Coke reacted with the un-blocked antibody-
functionalized gold nanoparticles. 
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3.9.2 Caffeine free Diet Coke™ vs Unreacted Nanoparticles 
As the name implies, caffeine free Diet Coke™ contains no caffeine. 
However as for regular Diet Coke™ it is sweetened with aspartame. If there is no 
unreacted glutaraldehyde molecules available for cross binding with aspartame, 
the average spectra of this and the unreacted nanoparticles should be identical.  
For this study we have performed a hierarchical PCA (HPCA). This 
technique allows us to include all of the spectral data for all samples. This allows 
any subtle differences to be accounted for, and is the most robust technique 
possible. HPCA was explained in the Materials and Methods chapter (section 
2.6.5).  
The results of this study are shown in figure 3.9.3 below. The HPCA had 
three significant components explaining 87.9% of the variation in spectral data. 
Component 1 comprised 48.5% of variation; component 2, 26.2% of variation 
and component 3, 13.1%.  
 
Figure 3.9.3 HPCA of the SERS spectra acquired from caffeine-free Diet Coke™ after interaction 
with the unblocked antibody-functionalized nanoparticles compared to the unreacted 
nanoparticles. 
54                     A Novel Identification Method for Ultra trace detection of biomolecules                            
Figure 3.9.3 clearly confirms that component 1 shows no distinction 
between the two groups of samples. Component 3 also shows no distinction (not 
shown in fig. 3.9.3). However with component 2, all the unreacted nanoparticles 
are negative, while all the caffeine free Diet Coke™ samples are positive. This is a 
distinctive verification that there is unspecified reaction between aspartame and 
unreacted glutaraldehyde sites. Therefore it is established that blocking of the 
glutaraldehyde linker nanoparticles is required. 
The above studies were repeated after blocking unreacted glutaraldehyde 
on the antibody-functionalized nanoparticles with ethylamine as per the 
procedure indicated in section 2.3.3. The retesting was carried out to investigate 
whether the blocking agent was successful in preventing the unwanted binding to 
interfering compounds.  
 
3.10 CONFIRMATION OF BLOCKING ADEQUACY 
The blocking adequacy was confirmed using firstly Coca-Cola™ vs Diet 
Coke™. As before, after that, unreacted nanoparticles and the caffeine free Diet 
Coke™ spectral data were obtained. The spectra for each study were averaged 
and compared for any variations in the corresponding spectra that would indicate 
the blocking was not adequate. This was followed up using PCA/HPCA 
respectively to further confirm the adequacy of the blocking step. 
 
3.10.1 Coke vs Diet Coke™ 
The PCA for Coca-Cola™ vs Diet Coke™ is found in figure 3.10.1. It 
comprises one component that explains 98.2% of the variation in the data. The 
two groups of samples are significantly overlapped in this graph. This is a 
probable indication of blocking adequacy. However the overall tendency shows 
Diet Coke™ more negative than regular coke. So further verification needs to be 
done to confirm whether the blocking was inadequate or was something else 
causing the overall tendency of differences between these two products. 
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3.10.2 Caffeine free Diet Coke vs Unreacted Nanoparticles 
HPCA was used in this study to provide the most robust confirmation of 
blocking adequacy possible. Figure 3.10.2 shows the HPCA analysis of the 
acquired SERS spectra. The HPCA had four significant components explaining 
95.9% of spectral data variance. Components 1-4 comprised 40.8%, 26.9%, 
17.4% and 10.9% respectively of the spectral data variance.  
Careful inspection of figure 3.10.2 shows that all four components are not 
able to distinguish between the unreacted nanoparticles and the caffeine free 
Diet Coke™ reacted nanoparticles. For the unreacted nanoparticle samples, some 
samples are negative and some positive in each component.  This also holds for 
the caffeine free Diet Coke™ samples in components 2 and 4.  For components 1 
and 3 the caffeine free Diet Coke™ samples fall within the range of the unreacted 
nanoparticle samples. This means that the two groups of samples are equivalent, 
and that the blocking step was adequate to prevent unspecific cross reaction. 
This implies that the negative tendency of Diet Coke™ (fig. 3.10.1) may have 
other origins. 
Figure 3.10.1 PCA of regular Coca-Cola™ vs Diet Coke™ 
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The ethylamine-blocked antibody-functionalized gold nanoparticles were 
then used in an overarching study involving a range of caffeinated beverages that 
contain different sweetening products as well as synthetic/naturally derived 
caffeine. This study was performed to determine if the nanoparticle could 
adequately distinguish caffeine in a range of complex matrices. 
3.11 COMPARISON OF CAFFEINE CONTAINING BEVERAGES  
The interference study was repeated using commercial beverages 
containing caffeine. These beverages were Cola flavoured beverages: regular 
Coca-Cola™ from Coca-Cola Company; along with two products with alternative 
sweeteners, Diet Coke™ from Coca-Cola Company containing aspartame as 
sweetener, and, Pepsi Next™ from PepsiCo containing Stevia extract as 
sweetener. 
Two energy drinks were also investigated, Red Bull™ regular from Red Bull 
GmbH containing only synthetic caffeine, and Monster Energy™ from the Monster 
Figure 3.10.2 HPCA of caffeine free Diet Coke™ reacted with the caffeine antibody functionalized 
blocked nanoparticles compared to the unreacted nanoparticle, to confirm that the blocking has 
worked. 
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Beverage Corporation containing both synthetic caffeine and naturally derived 
caffeine from Guarana seed extract. Coffee products were also used, they were, a 
short black (espresso) from a barista, and an instant coffee product -Italian 
Espresso Style coffee bag from Robert Timms. Figure 3.11.1 shows the spectra of 
the commercially available beverages included in this overarching study.  
NOTE: the antibodies used in this study were older so the nanoparticle 
background peaks differed from previous ones and difference from this 
background was used to determine caffeine binding. 
3.11.1 Caffeine in commercially available beverages 
The spectra acquired from reacting each of Coca-Cola™, Diet Coke™, 
Pepsi Next™, Red Bull™ and Monster energy™ beverages with the blocked 
antibody-functionalized gold nanoparticles were examined using PCA multivariate 
statistical analysis. The PCA for this study is shown in figure 3.11.2. The PCA 
model showed one significant component comprising 86% of the variance.  
Figure 3.11.1 Stacked SERS spectra of caffeine containing beverages reacted with blocked 
antibody-functionalized gold nanoparticles.  
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Red Bull™ is a product known to contain only synthetic caffeine. All the 
Red Bull™ samples are negative in component one. They are also found the 
furthest left of all the samples the PCA graph.  
Monster Energy™ contains synthetic caffeine as well as an extract from 
the Guarana plant. The Guarana plant is a natural source of caffeine. Half of the 
Monster Energy™ samples are significantly positive in component one. One of the 
other two Monster Energy™ samples resembles that of the Red Bull™ samples. 
Other than this sample, all the Monster Energy™ samples are on the right hand 
side of the graph.  
This mixed character of the Monster Energy™ samples reflects the mixed 
source of the caffeine in the product. One sample (on the far left) most likely 
primarily contains synthetic caffeine, three (on the far right) most likely contain 
only naturally derived caffeine and the other (towards the middle) probably 
contains a mixed source of caffeine. 
A published study examined the caffeine in Guarana and found that it 
forms a complex with the tannins compound that is known to be found in 
Figure 3.11.2 PCA for commercially available prepared caffeinated beverages using the 
major points of the caffeine is reaction with the caffeine antibody functionalized 
nanoparticle. 
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Guarana plants. the study proved that the interaction between caffeine and 
tannins was through the non-methylated nitrogen atom (N 9) and was most likely 
a hydrogen bond with a hydroxyl group on the tannin [43].  An earlier study of 
Guarana also came to this conclusion using a thin layer chromatographic 
technique and further analysis using mass spectroscopy, UV, IR and 'H NMR 
spectroscopy.  They compared Guarana extract with the same extract after 
treatment with a method used to remove tannins.  The treated Guarana extract 
reacted the same as caffeine in these techniques [65]. 
The actual ingredients of Coca-Cola™ are a trade secret.[66] However 
there has been a persistent rumour that historically Coca-Cola™ contained 
extracts from the Coke plant and the Kola plant, hence the name Coca-Cola™ 
derived from the two plant names with the K in Kola changed to C for marketing 
reasons.[67] There is no actual information available about the precise 
ingredients for Coca-Cola™ but the official UK Coca-Cola™ web page ingredients 
list for Coca-Cola™ includes “natural flavourings (containing caffeine)” [68]. This 
implies that Coca-Cola™ may contain an extract from Kola plant as its source of 
caffeine. 
In figure 3.11.2 the Coca-Cola™ samples act far more similarly to those of 
the Monster Energy™ samples, which are assumed to contain naturally sourced 
caffeine, than they do to the Red Bull™ samples. The majority of the Coca-Cola™ 
samples are positive in component 1 and on the right hand side of the graph. 
This is evidence in support of the rumour that Coca-Cola™’s caffeine comes from 
the Kola plant. 
The UK Coca-Cola™ web page ingredients list for Diet Coke™ has a subtle 
difference to that of the Coca-Cola™ web page (except obviously for the 
sweetener source). This is an omission of the word “natural” when describing the 
flavourings containing caffeine [69]. This implies that the source of the caffeine 
may be synthetic rather than natural even though the flavour is still that of Cola. 
Interestingly the Diet Coke™ samples in this study act very similarly to those of 
the Red Bull samples. All but one of the Diet Coke™ samples is closely similar to 
the corresponding Red Bull™ sample, i.e. negative in component 1 and on the 
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left-hand side of the graph. This is a confirmation of the hint from the UK Coca-
Cola™ web page that the source of the caffeine in Diet Coke™ is different from 
that of Coca-Cola™ and is not natural. 
The other beverage in this study is PepsiNext™. The Australian 
PepsiNext™ ingredients list contains caffeine and Natural flavours[70]. So the 
implication is that in PepsiNext™ the caffeine is of the synthetic variety. In this 
study the Pepsi Next™ samples act very much like the Red Bull™ samples even 
more so than those of Diet Coke™. This is strong confirmation that the caffeine 
source of Pepsi Next™ is synthetic. Consequently both Diet Coke™ and Pepsi 
Next™ will be omitted from the following study with naturally caffeinated 
beverages. Red Bull™ will be included only as a known source of synthetic 
caffeine for comparison purposes. 
 
3.11.2 Beverages with Naturally Occurring Caffeine 
The beverages included in this PCA Model were those commercial 
beverages identified in the last study as most likely containing naturally occurring 
caffeine i.e. Coca-Cola™ and Monster energy™. Also included were instant coffee 
from Robert Timms (Italian Espresso Style brand) and a short black (espresso) 
from a barista. As a comparison, Red Bull which is known to contain synthetic 
caffeine was included. SERS spectra of the beverages after their reaction with the 
blocked antibody-functionalized gold nanoparticles were processed and involved 
in the PCA model shown in figure 3.11.3. 
This PCA model has two significant components explaining 96.4% of the 
spectral variance: component 1 with 76.4 % of the variance and component 2 
with 20.0%. The red Bull samples in this model were tightly clustered and 
approximately centred on component one. They were all positive in component 2. 
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All but one of the Monster energy samples were loosely clustered furthest 
right (i.e. positive on component 1). They were also mostly negative on 
component 2. As in the study with commercially available beverages one of the 
monster energy samples is significantly different to the rest. 
The other group of samples whose average point is positive in component 
1 is Coca-Cola. All but one of its samples is positive in component 1 with the 
remaining sample just negative, and consistent with synthetic caffeine the. Coca-
Cola is the only group of naturally occurring caffeinated beverages whose 
average point is positive in component 2. 
The two groups of coffee samples were intermingled, as would be 
expected. The instant coffee is more closed tightly clustered which is not 
unsurprising as this is a commercial product and therefore probably more 
processed with meticulously controlled ingredients. This instant coffee is also 
close in character to Red Bull, the synthetic caffeine containing beverage. The 
company (Robert Timms) that produces this instant coffee states on the 
Figure 3.11.3 PCA of the all beverages containing naturally derived caffeine: Coca-Cola, 
Monster energy, instant coffee, short black (espresso). Red Bull is added to the list as a source 
of known synthetic caffeine for comparison. 
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packaging that the coffee bag contains both ground and soluble coffee. This may 
mean that some of it has been sufficiently processed that part of the caffeine 
content is free of any molecular complexing, i.e. equivalent to synthetic caffeine. 
 The espresso samples (short black shot) showed an interesting 
pattern in this model. The coffee is known to be of a blended source[71]. The 
three of the samples were almost superimposed. Two of the remaining samples 
were on the other two points of a triangle, with the last sample almost 
equidistant between these three positions. This would be consistent with a mix of 
three different sources with three points of the triangle indicating the three 
separate sources, and the equidistant point a mix of all three sources. These 
results imply that this technique may be able to distinguish between coffee beans 
from different sources and may imply wider applications to other 
plants/beverages derived from them. This is an area that requires further 
investigation.  
 
3.11.3 All Caffeine containing Beverages 
The spectral data of all of the investigated beverages were included in a 
third PCA model [figure 3.11.4) with two significant components comprising 96% 
of the spectral data variation overall. Component 1 explains 71% of the variance 
while component 2 explains 25%. The model indicated that the majority of 
Monster energy samples were positive in component 1.  
The Coca-Cola samples were placed very similarly to those in the previous 
models, but interesting findings about the Diet Coke can be seen. The Diet Coke 
samples were widely scattered in component 1 with the averaged data point 
practically neutral on component 2. The average data point for Diet Coke is 
almost superimposed upon the average data point of Pepsi Next, and both of 
them are very close to the Red Bull samples. Taking these points together it is 
further evidence that both of these cola flavoured drinks contain synthetic 
caffeine. 
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  As before in the naturally caffeinated beverages model the two coffee 
samples were inter-disbursed with the instant (Robert Timms) coffee samples 
more tightly clustered.  The PCA model also showed that the average instant 
coffee sample was very close in character to those of the Diet Coke and Pepsi 
Next, with one of the instant coffee samples so similar that it was concealed 
beneath that of the averaged Pepsi next. This is further evidence that the 
processing of the instant coffee may have produced at least some non-complexed 
caffeine approximating synthetic coffee.  
The average espresso coffee sample was far more negative on component 
1 than the average instant coffee sample, with half of the espresso coffee 
samples largely superimposed and the furthest left found. Both averaged coffee 
samples are, however, very similar on component 2. 
 
Figure 3.11.4 PCA of the major points in the Raman spectra of the caffeinated 
beverages reacted with the blocked caffeine antibody functionalized 
nanoparticles. 
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3.12 PRELIMINARY CONCLUSIONS AND RECOMMENDATIONS FOR 
THE CAFFEINE MODEL  
The caffeine study demonstrated that this new technique is suitable for 
ultra trace detection of caffeine and by extension other small molecules provided 
that a suitable antibody to the target analyte is used. The LLOQ found for 
caffeine standard solution was 1×10-10 M. This is magnitude significant 
improvement from of other techniques currently used for the detection of 
caffeine such as FT-Raman spectroscopy which has LLOD of 9.3×10-5 M [40]. 
In addition to its significant improvement in sensitivity and the non-
destructive nature of the analysis, this technique requires at only 10 µL of sample 
from standard solution or commercial beverages (such as soft drink or energy 
drinks) while FT-Raman requires 10 mL of sample for the analysis [40]. The 
developed technique combines immuno-separation with direct SERS analysis of 
the target analyte. The technique does not suffer from the problems of other 
Raman techniques where the spectrum of the analyte is completely swamped by 
the remainder of the sample, or misidentification of the trace analyte due to the 
presence of interfering compounds in the sample within the sample[43, 45].  
The new method does not require sample preparation and is applicable to 
liquid samples of complex matrices. These features along with the availability of 
commercial portable Raman spectrometers make the technique rapid, applicable 
to field screening scenarios and more user – friendly when compared to other 
techniques such as chromatography[40]. Therefore the developed technique has 
broad applicability in many fields such as pharmaceutical and food industries.   
This model showed some interesting preliminary features that should be 
pursued with further analysis to verify.  The guarana extract in Monster Energy™ 
with its complexed caffeine was different to the majority of other beverages that 
were trialled in this study as it is known to be complexed with tannins [43, 65].  
The Monster Energy™ samples had extreme positions on the caffeinated 
beverages PCA analyses [figures 3.11.2, 3.11.3 and 3.11.4].  In a follow-on 
study, another source of Guarana extract will be used to verify that this result is 
not an artefact but is fundamental to Guarana analysis, and more broadly to 
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analysis of naturally derived caffeine.  In addition, several other naturally 
caffeinated beverages, including tea and yerba maté will be used, to investigate 
the effects of the naturally derived caffeine on the developed method’s caffeine 
detection.   
This technique has been verified as suitable for ultra trace detection of 
small organic molecules, but for full applicability it needs to also be suitable for 
large and complex biomolecules.  The following model will repeat this verification 
using erythropoietin and so demonstrate the technique’s wide applicability. 
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Chapter 4: Erythropoietin Model 
4.1 GENERAL BACKGROUND 
4.1.1 What is Erythropoietin 
Erythropoietin, otherwise known as EPO, is a hormone predominately 
produced by the kidneys (>90%) in response to low blood oxygen levels, 
released into the blood and carried to the bone marrow.  Many other organs 
produce minor amounts of this hormone with the liver being the predominant 
alternative source of EPO production [72].  This hormone’s primary role is to act 
as chemical messenger that indicates to the bone marrow that more red blood 
cells are required. This message starts a process that leads to the genesis of 
additional red blood cells and a higher oxygen carrying capacity [72, 73].  
Erythropoiesis is the process for producing red blood cells. Substances that cause 
erythropoiesis are known as erythropoiesis stimulating agents (ESAs) [74]. 
EPO is a glycoprotein that has a protein core of 165 amino acids. EPO has 
three nitrogen-linked glycans (short carbohydrate chains) at amino acids number 
24, 38, 83 and one oxygen-linked glycan chain at amino acid number 126.  
Various forms of branching within these glycan chains are found[74].  The glycan 
chains may or may not have a terminal sialic acid group, leading to the isoelectric 
point (pI) ranging between 3.7 and 4.7 for human EPO[75].  
Because of the varying availability of glycosylation enzymes between 
organisms, each organism producing EPO has different patterns of branching in 
the glycan chains [76]. For example, while human cells can express sialyl-α 2-6 
transferase, bisecting N-acetyl glucosamine transferase, and α 1-3/4 fucosyl 
transferase, Chinese Hamster Ovary (CHO) cells do not [77-79].  There are also 
subtle differences in branching patterns between cell types within the same 
organism.[73, 74, 76]  These variations in charge or mass between individual 
molecules (isoforms) lead to characteristic differences in the recognition patterns 
of the various EPO isoforms, which are used by the current EPO detection 
methods to distinguish the various forms of EPO [80].  
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4.1.3 Forms of recombinant EPO Available and why they are needed  
Patients with end-stage renal failure suffer from an unusual form of 
anaemia that presents as haemoglobin deficient anaemia but does not respond to 
iron supplementation.  The diseased kidney is unable to produce the amount of 
EPO needed to signal the production of additional red blood cells.  Several 
recombinant forms of EPO have been developed to fill this therapeutic need [58, 
59, 67]. 
Various recombinant pharmaceutical preparations of EPO are currently 
available.  Different host cells are used to produce these forms.  The currently 
available recombinant Human EPO (rHuEPO) forms have been named using the 
term ‘epoetin’ followed by a letter of the Greek alphabet. Some early examples of 
these were epoetin alpha and beta, which are raised in CHO cells, and epoetin 
omega raised in baby hamster kidney (BHK) cells[77].  The first generation 
epoetins that are commercially available in Australia are Eprex (epoetin alpha, 
Janssen-Cilag Pty Ltd) and NeoRecormon (epoetin beta, Roche Australia Pty Ltd).   
First generation epoetins are now out of patent protection, and these 
forms of rHuEPO, particularly epoetin alpha, have been produced by many 
companies in the world as generic products[81].  A new epoetin form known as 
epoetin delta, the first rHuEPO that had been raised in human cells (human ovary 
cells), appeared on the market about a decade ago but was withdrawn for 
commercial reasons in 2009 [74, 82].   
In addition to these rHuEPO products, two other modified rHuEPO 
compounds, MINCERA™ and Aranesp™, have been produced.  MINCERA™ is 
epoetin beta with a polyethylene glycol (PEG) group attached to a primary amine 
on one of either the N-terminals or the amino acid lysine, particularly amino acid 
number 45 or 52 [83].  The PEG attachment significantly increases the 
pharmacological half-life of the compound in blood, which means that the 
frequency of administration that is required is significantly decreased.  PEG 
modification essentially doubles the molecular weight of the ESA to approximately 
60 kDa [82]. 
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Aranesp™ also has a similarly long biological half-life but achieves it by a 
different mechanism.  Aranesp™ is epoetin alpha, which has amino acid 
substitutions in the EPO protein core. These substitutions allow for two extra 
glycan chains to be attached to the EPO core.  The attached glycan chains resist 
degradation and removal of the enzyme by the kidneys [74]. The extra glycan 
chains increase the weight of Aranesp™ to 37 kDa.  
4.1.4 The history of athletes’ exploitation of rHuEPO 
Athletes who wish to dope commonly exploit new medical developments to 
get better results than their competitors.  RHuEPO was no exception.  Athletes in 
endurance sports quickly realised the benefits of doping with rHuEPO to increase 
the capacity of their blood to carry oxygen and their endurance in competitions. 
Although rHuEPO was banned by a number of sporting bodies [76, 84] including 
the Olympic organisation in 1990 [85], there was no direct analytical test 
available to monitor rHuEPO doping. It was suspected that the illicit use of 
rHuEPO in sport became widespread in the late 1980s, soon after it became 
commercially available. In the late 1990s, a direct test for rHuEPO became 
available, however this test was unreliable [76].  The suspicion of rHuEPO doping 
was ultimately confirmed in 1998.  
The 1998 Tour de France cycling competition was notorious for doping 
scandals, and is known as the Festiva affair.  It started with the seizure of a 
significant haul of doping products, including rHuEPO, from a car belonging to a 
Festiva cycling team official, leading to searches of athlete hotel rooms and team 
investigations.  Several teams, individual athletes and Coca-Cola, a major 
sponsor, subsequently withdrew from the race [86]. A spate of confessions by 
current and retired riders to the use of rHuEPO and other banned drugs followed.  
Officials of the Festiva cycling team, including team doctors, pharmacists and 
managers were arrested, tried and convicted with charges relating to “aiding and 
inciting the administration of illegal doping substances” [87] and fines and 
suspended sentences were handed down [87].  
This pivotal event in anti-doping history highlighted the need for a global 
strategy to fight against doping in sport, and was the impetus for the founding of 
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the World Anti-Doping Agency (WADA) [85, 88].  The 1998 Tour de France is still 
the scandalous benchmark against which all sports doping is measured [89].  
4.1.5 The implications of doping for the athlete, sport and country 
Athletes involved in drug, protein or gene doping face long term and wide 
spread consequences. The athlete’s integrity and reputation is enormously 
damaged when he/she is linked to illegal doping.  If a ban is applied, the athlete 
potentially loses years of competition during the most productive years of his or 
her career and can fall out of the public eye for many years. This greatly 
diminishes his/her appeal to sponsors.  
When multiple athletes within a sport are caught doping, the negative 
consequences extend beyond the individual athlete, and the reputation of the 
sport as a whole can also suffer. EPO and anabolic steroid doping in competitive 
cycling during the late 1990’s threatened the continuation of the world’s premier 
cycling event, the Tour de France. This is reflected in a statement written by a 
spectator on the pavement during this event: “EPO = mort du tour” (i.e. EPO is 
the death of the Tour)[86], and on the official Tour website: ”Le Tour was 
rocked” describing the 1998 Tour [90]. 
In addition, as athletes often represent countries when they perform, the 
reputation of the nation and other associated athletes can suffer, as evidenced by 
the systematic doping of East German athletes in the 1970’s and 1980’s. While 
this was long suspected, it was only confirmed after the fall of the Berlin Wall 
[85, 91]. Germany has struggled to regain its sporting reputation in the decades 
that followed [92].  
4.1.6 Detrimental health effects of doping 
Many substances that are associated with illegal doping, including rHuEPO, 
impact negatively on the athlete’s health; and can continue to plague the athlete 
many years after their athletic career ends. Former East German athletes 
involved in the state run doping program in the 1970’s and 80’s are still suffering 
the side effects of the abuse of steroids forced upon them [92].  
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The un-regulated use of rHuEPO can cause antibody-induced red blood cell 
aplasia (PRCA), which is an immune response to the artificial EPO [74, 93]. While 
rare, this condition is very debilitating, and expert handling and administration is 
need to minimise its occurrence [93]. Other grave and more common secondary 
effects of self-administered rHuEPO also exist.  
EPO stimulates the production of red blood cells. This leads to increased 
blood viscosity[94], which can cause many cardiovascular problems including 
hypertension, strokes and heart attack.  Patients undertaking rHuEPO therapy 
must have their blood pressure carefully monitored as the treatment with rHuEPO 
can lead to an increase in blood pressure, and the safe level of rHuEPO in 
therapy varies between patients [73, 94].   
The misuse of rHuEPO has led to the sudden death of athletes in 
competition and training. Soon after rHuEPO became available in Europe, more 
than a dozen Dutch and Belgian cyclists died of sudden heart attacks at rest.  
This is thought to have been caused by doping with rHuEPO, although no test 
was available at the time to confirm this [91, 95].  
4.2 CURRENTLY USED OR PROPOSED TECHNIQUES FOR 
DETECTION OF DOPING WITH rHuEPO 
4.2.1 Double Blotting 
The use of EPO by athletes was banned by the International Olympic 
Committee in 1990[76, 84].  However, it was 10 years later that the first 
analytical technique to detect EPO in athlete’s urine was available.  Prior to this, 
only indirect methods were available to suggest the possibility of EPO abuse.  The 
indirect tests only indicated whether an athlete’s haemoglobin level was higher 
than was normal. These tests were unable confirm actual doping, as the normal 
haemoglobin range can vary significantly [91].  
In June, 2000 in a Brief Communication in Nature, the research group led 
by Françoise Lasne at the French National Anti-Doping Laboratory announced a 
direct detection technique for EPO in athlete’s urine [76].  This involved a 
modification of the common isoelectric focusing (IEF) technique with a blotting 
 A Novel Identification Method for Ultra trace detection of biomolecules                      71                                                    
technique used in biochemistry, i.e. a western blot, where a second blot was 
taken of the original blot and the new method was called the double blotting 
technique [96].  
Other modifications were later applied to improve this technique. This 
technique, with its modifications, constitute the basis of the current World Anti-
Doping Association (WADA) approved analytical protocol for EPO detection 
(WADA Technical Document TD2013EPO) [80]. 
A gel electrophoresis method that uses sodium dodecyl sulphate 
polyacrylamide electrophoresis (SDS-PAGE) has also been developed and 
approved by the WADA protocol [80]. However multiple criticisms of these 
techniques have been raised. 
4.2.2 Criticisms of the current method 
The first criticism involves the antibody used to detect EPO.  Several 
research groups have reported that the antibody (AE7A5, from R&D Systems), 
which is considered the critical reagent in this technique[80], is not specific to 
EPO [97-101]. Several other peptide hormones of similar profile (both in weight 
and pI) to EPO and found in human urine, cross react with AE7A5 [98].  This is 
important because the two techniques approved rely on these two characteristics. 
IEF relies on the differences in pI between molecules; and SDS-PAGE relies on 
the differences in weight [80]. 
Another criticism of the current technique is that the profile of EPO in urine 
can vary immediately after intense exercise. These changes may involve the 
identification of endogenous human EPO as rHuEPO [102]. 
The serum profile of endogenous EPO is similar to that of epoetin β, and 
the more basic isoforms of EPO that are not normally passed into the urine can 
be identified after exercise, as can other proteins (proteinuria) [97]. The main 
defence against this and the previous criticism is that experienced anti-doping 
scientists should be able to tell the difference between endogenous and 
recombinant EPO, even with these exercise induced EPO profiles [103-105].   
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Reproducibility between anti-doping laboratories was also criticised in the 
literature [106].  It has been argued that the same standards should be applied 
in anti-doping laboratories that are used in clinical laboratories, and that 
improvements can and should be made [107].  These topics are hotly debated, 
however, with the laboratories conducting these tests arguing adamantly that 
their tests are reliable [103-105], even with evidence to the contrary. 
The limit of detection in the currently sanctioned test is also relatively 
high, which requires a large quantity of urine, 20 mL [84]. The sample must then 
be concentrated at least 200 times to make the EPO detection possible, which is 
both time and labour intensive [84]. In addition to narrowing the window of 
opportunity to detect doping, the above problems increase the potential of false 
negatives and false positives.  False negative tests could result from careful 
planning of doping regimes by athletes so that the level of EPO in their urine is 
below the limit of detection on the day of competition, while still gaining benefit 
from increased red blood cell concentration and corresponding oxygen capacity 
[106, 108].  False positive results are minimised by careful and experienced 
analysts.  
Other issues with the current technique include the difficulty to establish 
the presence of recombinant EPO when there is a low concentration of EPO in the 
urine and/or a combination of both endogenous and recombinant EPO are 
present [109]. Also, the cost and time required for the current testing regime 
severely limits its suitability for out of competition testing (the best way to catch 
and discourage athletes doping) [106].  
Between batch variations have been reported for epoetins alpha and beta 
[110].  In addition, many different biosimilar EPO preparations have been made 
around the world, particularly forms of epoetin alpha [81]. The difference 
between batches of the same epoetin and between different epoetins is 
attributed in part to the cell lines used for the recombinant protein production, 
culture conditions and purification regimes [81, 109, 110]. These differences may 
cause the isoelectric point (pI) of endogenous EPO and rHuEPO to overlap, which 
potentially hampers the detection of rHuEPO by methods that rely on the pI 
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measurement. The difficulties in using the current technique to detect 
erythropoiesis stimulating agents (ESAs) and its limited ability to detect low levels 
of the analytes have spurred interest in developing new techniques for this 
purpose.   
4.2.3 Membrane-Assisted Isoform Immunoassay for EPO detection  
Recently, a new technique for the detection of EPO, Membrane -Assisted 
Isoform Immunoassay (MAIIA) was proposed [111].  In this technique the 
protein isoforms are first separated using lectin affinity chromatography [112]. 
The EPO isoforms are captured using an antibody specific to the protein and 
detected with a complimentary antibody that is attached to carbon black[113] 
The process uses a Lab-on-a-chip device and is read using a flatbed 
scanner[113]. This technique reportedly requires small volumes of urine samples, 
increases the ability to detect rHuEPO in the presence of endogenous EPO, lacks 
technical difficulty and uses relatively inexpensive equipment [111, 113-115].  
However, a group of Australian researchers recently tested the MAIIA 
technique and reported reliability and sensitivity issues. These problems included 
the lack of reproducibility between repeated tests and the increased potential for 
human error due to the multistage nature of the technique [114].  
When the MAIIA technique was evaluated again with an improved test kit, 
the researchers concluded that the MAIIA technique had the potential to detect 
EPO micro-dosing for at least 12 hours longer than the currently approved 
method can [116]. The disadvantages of the MAIIA technique include the difficult 
modification of the technique for on-site analysis and the requirement for 
laboratory testing.  
Other improvements to the analysis of EPO include an EPO immunoaffinity 
column [117], which is used for EPO purification prior to the MAIIA analysis, and 
is also a useful and recommended pre-analysis step for the currently used 
technique [80].  The antibody used for this immunoaffinity separation (Anti-hEPO 
antibody 3F6) has been shown to be ideal for applications requiring high 
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association rates and low disassociation rates, and reacts with very low levels of 
EPO [115]. 
4.2.4 Other proposed techniques for EPO and hormone detection 
Various techniques based in chromatography with mass spectrometry (MS) 
have been attempted for EPO analysis.  Many of the chromatography-based 
methods have been unsuccessful for human doping purposes [118, 119]. 
However, when rHuEPO is used to dope horses there is sufficient difference 
between horse EPO and human EPO for this to be detected by chromatographic 
methods [119].  Guan et al. successfully used GC-MS for the detection of rHuEPO 
doping in racehorses [120-123].  However the reported methods were not 
sufficiently sensitive for the detection of extremely low concentrations of the 
glycoproteins in biological fluids [119].  
Another technique, based on the distinctions of reactions between lectins 
and glycoprotein modifications of peptide hormones, has been proposed by Ukei 
et al [124, 125].  The technique is based on a lectin microarray.   
The microarray includes three lectins that recognise sialyl alpha 2-6 linked 
galactose/ galactosamine moieties on the glycans.  In this method, the lectins 
react only with endogenous EPO.  rHuEPO does not contain these moieties as the 
cell line (CHO) used to raise rHuEPO lacks the enzymes required to express these 
linkages [77-79]. Therefore, it is possible to distinguish between endogenous and 
recombinant EPO.  This technique is more sensitive than mass spectrometry 
based systems [125]. 
4.3 AIMS OF THIS EPO MODEL 
The aims of this model for EPO detection by functionalized gold 
nanoparticles and SERS are twofold.  The first is to develop a proof of concept for 
a new rapid, robust, easy and portable screening technique to detect ultra-trace 
amounts of EPO for anti-doping, forensic and bio-medical applications. 
The second aim of this model is to demonstrate the applicability of the 
SERS-based method for high molecular weight complex biomolecules as well as 
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low molecular weight small molecules such as caffeine. This is intended to 
present the method to the diverse field of analytical and bioanalytical chemistry. 
4.4 NANOPARTICLE CHARACTERISATION 
The nanoparticles were characterised as described in section 2.4 of the 
materials and methods chapter (chapter 2).  Briefly, they were analysed visually, 
then with UV-VIS spectroscopy, then further characterised using TEM. 
 
4.4.1 Visual Inspection 
The colour changes of the gold nanoparticles upon the immobilization of 
the anti-EPO antibodies and the ethylamine blocker were similar to those 
observed upon the development of the caffeine antibody-coated gold 
nanoparticles. The purple red colour of the silica-coated gold nanoparticles 
changed to bluish grey upon the addition of the glutaraldehyde linker and black 
with the anti-EPO antibody [Fig. 4.4.1]. 
Figure 4.4.1  Photograph of (L-R) Bare Gold nanoparticles, 
Silica coated nanoparticles, Nanoparticles with 
Glutaraldehyde linker, and completed nanoparticle with EPO 
antibody attached and blocked. 
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4.4.2 UV-Vis Characterisation 
UV-Vis spectroscopy of the nanoparticles showed that both the bare and 
silica-coated nanoparticles have the same absorption band at 525 nm. This is 
consistent with the preservation of colour between the two.   The silica coated 
nanoparticles have a marginally wider peak width however.  [See Fig. 4.4.2].    
Both the glutaraldehyde linked nanoparticles and the completed 
nanoparticles with antibody and blocking show no visible peak. This is probably 
because there is a wide variation in size between nanoparticle clusters as was 
found in the caffeine model, and the nanoparticle clusters’ light scattering.  This 
result indicates the successful immobilization of the anti-EPO antibody onto the 
gold nanoparticles. 
 
Figure 4.4.2 UV-Vis spectra of the bare gold nanoparticles, silica-coated nanoparticles, 
nanoparticles with glutaraldehyde linker attached and the completed nanoparticles with the EPO 
antibody (MAIIA, 3F6) and blocking 
4.4.3  TEM Characterisation 
Bare gold nanoparticles  
The average bare gold nanoparticle was largely quasi-spherical (81%) with 
a further 8% appearing to be elongated spherical nanoparticles, as if they had 
joined early in the manufacture. [Note: The red boxed nanoparticle in the TEM of 
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silica coated nanoparticles (fig 4.4.6] appears to show this joining.] TEM 
photographs of the bare gold nanoparticles are shown in figure 4.4.3, and the 
corresponding graph analysing 140 of these nanoparticles in figure 4.4.4. 
Figure 4.4.3 TEM of Bare gold Nanoparticles 
 
Figure 4.4.4 Determination of the sphericality of the nanoparticles.  The nanoparticles are 
largely spherical or quasi-spherical (81%).    
The nanoparticle diagonal sizes (mean and median) were 22.80 nm and 
22.85 nm respectively, with a standard deviation (SD) of 3.2 nm [fig 4.4.5].  The 
size of the nanoparticles was calculated using the average of two dimensions for 
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spherical or elongated nanoparticles.  For any polynomial nanoparticles the 
average was calculated using sum of Apex to middle of opposite side for all 
apexes, divided by the number of sides.  
The majority of the peaks (89%) were sized between 18 and 27 nm which 
is +/-1.5 SD of the mean, with 74 % of total nanoparticles within 1 SD of the 
mean (19.6 - 26 nm).  So the size distribution of the bare Gold nanoparticles is 
22.8 +/- 3.2 nm using 1 SD as the error.   
 Silica Coated Nanoparticles  
The TEM photos indicated that the thickness of the silica coating on the 
silica-coated nanoparticles was from 0.65 nm to 2.94 nm with the majority of the 
nanoparticles having a silica coating thickness of approximately 1.3 nm [fig. 
4.4.6].  
Tian et al have reported that the Raman spectrum is enhanced by a thin 
coating of silica on a gold nanoparticles [126].  The authors attributed their 
finding to the enhancement the nanoparticles electric field by the thin silica 
coating and the development of hotspots.  The silica coat is a physical barrier 
Figure 4.4.5 Distribution of the average diameter of the bare Gold nanoparticles 
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preventing the ‘dilution’ of the LSPR by the movement of electrons between 
nanoparticles. The resulting two separated LSPR regions form a hotspot. Tian et 
al indicated that a silica coating of approximately 1 nm, leads to double the SERS 
enhancement that can be developed by un-coated (bare) gold nanoparticles. A 
similar effect was indicated by Liu et al for carbon coated silver nanoparticles 
[126-128].  The authors found that 0.5 nm coated nanoparticles had 
enhancement more than four times that of the bare nanoparticles. Therefore it is 
expected that the silica coating of the EPO antibody-functionalized gold 
nanoparticles to contribute positively to the SERS screening by the developed 
nanoparticles due to its ability to increase the SERS enhancement of the 
nanoparticles. 
Addition of glutaraldehyde linker to the silica-coated nanoparticles 
When glutaraldehyde was added to the APTMS primed silica-coated nanoparticles 
the formation of aggregates was noticed and lead to some nanoparticle clusters. 
Figure 4.4.7 shows a typical TEM of nanoparticles clusters. The clustering of the 
nanoparticles is attributed to the uncontrolled cross linking of some nanoparticles 
via the glutaraldehyde linker as the linker has two active aldehyde terminals that 
can interact with the silica coating of separate nanoparticles. This involves the 
reaction between glutaraldehyde and the terminal amine groups of the APTMS 
primed silica shell [38]. 
Figure 4.4.6 TEM of silica coated nanoparticles 
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Immobilization of the EPO antibody onto the nanoparticles  
The immobilization of the 3F6 EPO antibody onto the gold nanoparticles occurs 
by the formation of a linkage between an aldehyde moiety of the glutaraldehyde 
linker and any of the amine groups on the antibody molecule. As in the case of 
the addition of the glutaraldehyde linker to the gold nanoparticles colloid, some 
aggregation was also noticed upon the addition of the antibody to the 
nanoparticles colloid (figure 4.4.8). This can be attributed to the bridging 
between the nanoparticles through the glutaraldehyde and antibody bridges.  
Figure 4.4.7 TEM of nanoparticles with linker 
Figure 4.4.8 TEM of aggregates formed during 
the addition of the EPO antibody to the of the 
gold nanoparticles colloid 
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Figure 4.4.9 shows a schematic diagram of the proposed cross linking 
between the antibody-functionalized nanoparticles to form aggregates. While the 
aggregation of nanoparticles may be of value to surface enhanced Raman 
spectroscopy as it favours the formation of hot spots that cause significant signal 
enhancement, the use of a more controlled linker molecule other than 
glutaraldehyde would lead to a greater reproducibility of our proposed technique.  
A suitable linker that can be used to immobilize the antibody, while avoiding the 
uncontrolled aggregation of some of the nanoparticles, would be asymmetric 
molecule that link to the nanoparticles via one terminal group and binds to the 
antibody via a different terminal group. 
For example, cysteamine is able to adhere to gold surface via its -SH 
moiety to form a thiol linkage.  The other terminal of the cysteamine molecule is 
a primary amine group that can form a strong amide linkage with the carboxyl 
groups on the antibody. Therefore the cysteamine can be used to immobilize the 
antibody without inducing uncontrolled aggregation of the nanoparticles through 
the linker bridge.    
The only possibility for cross linking between the nanoparticles, will be 
through the antibody as it has many carboxyl groups that can bind to cysteamine 
linker moieties on separate gold nanoparticles. The aggregation of the 
Figure 4.4.9 Schematic diagram of cross linking between gold nanoparticles via the 
glutaraldehyde and antibody bridges  
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nanoparticles will be more controlled in this case and may lead to the favoured 
hotspots without the formation of oversized clusters.  Hotspots would only form if 
the gold nanoparticles were sufficiently close together. 
 
Confirmation of nanoparticles clusters structure  
To confirm the structure of the functionalized nanoparticles clusters, 3 
aliquots of the functionalized nanoparticles colloid were boiled with deionised 
water, 1 M HCl and concentrated HCl (32%) respectively, for one hour.  When 
the nanoparticles colloid was boiled in water no change in colour was observed.  
However the colloids that were boiled with the dilute and concentrated HCl 
showed a brownish colour which when viewed obliquely showed a reddish tint.  
The change in colour was rapid when the colloidal nanoparticles were boiled with 
the concentrated acid and occurred in few minutes but much slower with the 
dilute acid (Fig 4.4.10).  
Figure 4.4.10. Functionalized colloidal nanoparticles after digestion for 
one hour in left) 1 M HCl, middle) deionised water and right) 32% HCl 
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4.5 INTERACTION BETWEEN THE ANTIBODY-FUNCTIONALIZED 
NANOPARTICLES AND HUEPO 
In order to investigate the interaction between HUEPO and the EPO 
antibody-functionalized nanoparticles, the nanoparticles were reacted for 30 
minutes with 10-8 M HUEPO standard solution and screened by SERS [fig. 4.5.1]. 
The SERS spectra of the un-reacted functionalized nanoparticles were also 
collected as the reference background. The spectra were visually inspected. This 
was carried out to identify the Raman spectral lines of the functionalized 
nanoparticles background and any new Raman bands that were developed due to 
the binding between HUEPO and the functionalized nanoparticles.  
The EPO molecule is a large and complicated one.  No spectral assignment 
has been attempted because the non-uniform orientation of the antibodies and 
the multiple isoforms lead to significant variability and difficulty in assignment of 
any spectral features.  Rather only the differences to the unreacted nanoparticles 
spectra were noted.  
 
After processing, the Raman bands at 422, 440, 916, 1176, and 1621 cm-1 
were shown to be a result of the interaction between the HUEPO analyte and the 
Figure 4.5.1 SERS spectra of un-reacted antibody-functionalized gold nanoparticles and 
antibody-functionalized nanoparticles reacted with 10-8 M HUEPO 
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antibody-functionalized nanoparticles.  Peaks at 525, 725, 802, 1365, 1385, 1515, 
1538, 1585 cm-1 were also related to HUEPO but less prominent [Fig 4.5.1].  The 
prominent bands of the un-reacted nanoparticle were found at 660, 1000, 1030, 
1045, 1224, 1514 and 1599 cm-1 [fig. 4.5.1]. 
 PCA confirmed that there is a statistical difference between the SERS 
spectra of the unreacted nanoparticles and those reacted with HUEPO. The PCA 
model (Fig. 4.5.2) indicated that there is a clear separation of the two groups  
with both groups fitting comfortably within the model and no outliers from either 
group.  This result confirms that proposed SERS screening by the EPO antibody-
functionalized gold nanoparticles is able detect ultra-trace amounts of EPO in 
solutions.  
Figure 4.5.2 also shows that the unreacted nanoparticles are tightly 
clustered, whereas the nanoparticles reacted with HUEPO are far less tightly 
clustered i.e. the spectra of the unreacted nanoparticles are more reproducible 
than those of the reacted nanoparticles.  This is not unexpected as the spectrum 
of the reacted nanoparticles would vary according to the orientation and location 
Figure 4.5.2 Distinction between unreacted nanoparticles and nanoparticles reacted with 
1×10-8 M HUEPO.   
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of the antibodies in relation to the hotspots and which antibodies the HUEPO 
reacts with.  
4.6 EFFECT OF TIME ON THE BINDING BETWEEN 10-8 M HUEPO 
AND ANTIBODY-FUNCTIONALIZED GOLD NANOPARTICLES  
This study was performed to determine the optimal reaction time that gives 
maximum binding of the EPO analyte with its antibody-functionalized 
nanoparticle.  A 10-8 M standard solution of EPO was mixed with its functionalized 
nanoparticle for a series of increasing times between 0 and 600 minutes before 
screening by SERS.  The spectra were superimposed and the major peaks were 
visually inspected to determine when no significant change in peak heights with 
increasing time was observed.  (This is shown in Figure 4.6.1 with Reaction time 
plotted against Peak height.) This was observed after 30 minutes of interaction 
between the analyte and the functionalized nanoparticles. Therefore the optimal 
reaction time was determined to be 30 minutes. 
Figure 4.6.1 Determination of optimal reaction time between 1 x 10-8 M HuEPO standard 
and antibody-functionalized gold nanoparticles.  The normalised peak intensities of 
various Raman bands (indicated by the inset) are plotted against the reaction time.  
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NOTE: The immobilized antibody was anti-EPO antibody 3F6 from MAIIA. 
This antibody was demonstrated by the manufacturers to have a very rapid 
reaction with its EPO analyte [115]. This allowed the peak found at 0 min in 
figure 4.6.1. 
4.7 DILUTION SERIES USING STANDARD SOLUTIONS 
This study was performed to develop a calibration curve of the analyte.  After 
careful inspection of the qualitative data, the bands at 422 cm-1 and 440 cm-1 
were found to fulfil the criteria outlined (RSQ ≥ 70%). PLS of these two points 
was also attempted to determine whether it would yield a better result than 
univariate regression.  The PLS R2 values were worse than the RSQ values for the 
nominated peaks. Figure 4.7.1 shows the log linear relationship between the 
peak intensity at 422 cm-1 and the EPO concentration (on a log scale) in the 
range 2x10-10M to (LLOQ) 3.5x10-13 M using the inflection point. If 3*SD of 
background is used as the LLOQ this gives a LLOQ of 1.3x10-13 M (using the 
equation of the quantification region).  
Figure 4.7.1 Log10 calibration curve using area-normalised peak intensity at 422 cm
-1 of EPO 
solutions in the range 2 x 10-10 M to Lower Limit of Quantification (LLOQ) = 3.5x10-13 M.  
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Taking the larger of these two measurements we determine the LLOQ to be 
3.5x10-13 M. 
The lowest concentration measured was 10-15 M (Fig. 4.7.1) at intensity of 
0.0271, while the average nanoparticle background is 0.0092. A robust definition 
for the limit of detection is: 
LLOD= mean(background)+1.654*SD(background)+1.654*SD(low concentration sample)[129] 
If 1×10-15 M is used as the low concentration sample, LLOD is 0.0243, (7.4 x 10-19 
M i.e. ~16 molecules of EPO) using the equation of the curve after the inflection 
point.  While this is not unobtainable with parameters maximised, (i.e. the thin 
pacification layer, significant clustering of the nanoparticles, optimal orientation of 
the antibody and multiple hotspots within the sampled area), we conservatively 
nominate the lowest concentration measured (1 x 10-15 M) as the LLOD. 
The average EPO concentration in human serum is 2.5 X 10-12 M and 2.5 x 
10-13 M in urine respectively. These concentrations were within the linear range of 
Figure 4.7.2 Linear calibration range 2.5X10-12M to 2.5 x 10-13M (on log scale), 
corresponding to blue dotted box in fig 4.7.1 
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the calibration curve shown in figures 4.7.2, (Corresponding to blue dotted box in 
4.7.1). This indicated the applicability of the developed method for the detection 
of EPO in biological samples of ultra trace concentration levels below.      
   
4.8 CROSS REACTIVITY OF THE EPO ANTIBODY-
FUNCTIONALIZED NANOPARTICLES WITH PROTEIN MATRIX  
This study was carried to determine whether the EPO antibody-
functionalized gold nanoparticles interact non-selectively with other proteins that 
may co-exist in a complex matrix such as biological fluids. Non selective 
interaction with proteins other than EPO would typically lead false positives. 
Therefore it was necessary to investigate the cross reactivity of the antibody-
functionalized gold nanoparticles despite the fact that the immobilized 3F6 anti 
EPO antibody is certified by, MAIIA diagnostics, to be of very high selectivity 
towards EPO [76].  
For this study, the EPO antibody-functionalized gold nanoparticles were 
mixed with skim milk. The skim milk matrix consists of a variety of proteins that 
would react with the EPO antibody only if the antibody has cross reactivity 
towards these proteins. In addition the skim milk proteins contain primary amines 
that would react with any un-blocked aldehyde group of the glutaraldehyde 
linker. It worth reminding that, the antibody-functionalized nanoparticles are 
always reacted with ethylamine upon their development. This is carried out as 
described in chapter 2 “materials and methods” to block any residual un-reacted 
aldehyde group of the glutaraldehyde linker after the immobilization of the 
antibodies.  
SERS spectra (12 measurements per sample) were obtained from the 
blocked antibody-functionalized gold nanoparticles after their reaction with milk 
sample and from un-reacted nanoparticles.  The spectra were compared for any 
variations that would indicate cross reactivity with the 3F6 antibody and/or 
binding to the glutaraldehyde linker. The spectra (Fig 4.8.1) showed no major 
variation between the unreacted and the reacted antibody- functionalized gold 
nanoparticles. One spectrum for each group had a noticeably different 
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background, see figure 4.8.1). The peak positions for the outlier spectrum 
coincided with the other spectra, however. So, this result indicated that there was 
most likely no cross reaction between the skim milk proteins and the 3F6 
antibody. 
 
For further substantiation, HPCA was performed using the entire spectral 
data from repeated SERS measurements of the un-reacted and reacted 
nanoparticles. The developed HPCA model (Fig 4.8.2) confirmed that the spectral 
data from both the unreacted and reacted nanoparticles were very closely 
clustered with only two outliers.  The two outliers in the HPCA model correspond 
to the outlier spectra, (fig 4.8.1). The difference in background baseline 
contributed in part to the non-clustering of these samples with the rest of the 
spectra despite the fact that there were no noticeable differences in the peak 
positions of the two samples, however they are similar to each other. Therefore, 
it is confirmed that there were no unblocked linkers available to cross react with 
the milk proteins. This result gave confidence that the developed EPO antibody-
functionalized gold nanoparticles can be used for the selective detection of EPO in 
biological samples such as urine.  
Figure 4.8.1 SERS spectra of the blocked EPO antibody-functionalized nanoparticles (un-
reacted with skim milk), the nanoparticles after reaction with skim milk and a representative 
outlier spectrum. Close correspondence of major peaks heights and positions is noticed. 
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4.9 APPLICATION OF THE DEVELOPED METHOD TO THE 
DETECTION OF EPO IN BIOLOGICAL SAMPLES 
4.9.1 Can the nanoparticle separate EPO from urine? 
To investigate the use of functionalized nanoparticles for the detection of 
EPO in a urine matrix, the functionalized nanoparticles were reacted with a self-
donated (from a person not receiving EPO treatment) urine sample. Another 
aliquot of the functionalized nanoparticles was reacted with a 1 × 10-9 M HUEPO 
IS solution in PBS buffer (pH 7.4). The spectral data in figure 4.9.1 showed that 
the major peaks indicative of the EPO binding to the functionalized nanoparticles 
also existed in the SERS spectrum of the tested urine sample. The close 
wavenumber correspondence between the HUEPO spectrum and the urine 
spectrum clearly indicate that the EPO antibody-functionalized nanoparticles were 
able to detect the natural EPO that is excreted in human urine. 
Figure 4.8.2 Hierarchical PCA (HPCA) of Raman spectra (354 -1627 cm-1). 
Black diamonds are un-reacted nanoparticles; grey triangles are nanoparticles 
reacted with skim milk.   
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4.9.2  Using standard solutions  
This interference study was an initial test to determine whether 
endogenous and recombinant EPO could be distinguished. It was performed 
using the 2nd international reference standard for HUEPO and the 3rd 
international reference standard for rHuEPO both at the concentration of 1 x 10-13 
M.  The SERS spectra are shown in figure 4.9.2.  
The spectra were found to be very similar to each other and indicated the 
successful binding between the EPO standards and the functionalized 
nanoparticles. However, there is some minor variation between the HUEPO IS 
and the rHuEPO IS at approximately 1540 cm-1.  See Fig. 4.9.2 below.  
 The consistency between the HUEPO and rHuEPO spectrum is not 
surprising.  HUEPO and rHuEPO (epoetin α) have only minor differences in the 
branching patterns of their glycan chains.  Therefore it would be expected that  
Figure 4.9.1 Comparison between a spectrum of 1 x 10-9 M HUEPO and a spectrum of 
human urine (from a donor not receiving EPO treatment).  The major peaks indicative of 
the EPO binding to the blocked antibody-functionalized gold nanoparticles are found at 
422, 440, 525, 725, 760, 800, 915, 1176, 1585 and 1620 cm-1 
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the Raman spectra of these two molecules when reacted with the 
functionalized nanoparticles to be largely similar. 
4.9.3 Spiked vs non-spiked urine samples 
 Urine vs. urine spiked with rHuEPO  
Urine samples were spiked with 10-12 and 10-14 M rHuEPO respectively, 
interacted with the EPO antibody-functionalized nanoparticles for 30 minutes and 
screened by SERS. For comparison, another urine sample, with no added 
rHuEPO, was also reacted with the functionalized nanoparticles and screened by 
SERS. The collected spectra (Fig 4.9.3) were inspected visually and a series of 
preliminary PCA were done selecting blocks of the spectra that were known to 
vary with EPO binding and not the nanoparticle.  Upon careful study of the 
spectra subtle differences are present in spectral region 1515 cm-1 to 1580 cm-1 
(the grey-shaded region in Fig 4.9.3). The PCA performed using this region 
showed the best distinctions between the human and recombinant EPO.    
 
 
Figure 4.9.2 Comparison of 1 x 10-13 M international standards of HUEPO and 
rHuEPO 
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In the PCA model, (fig 4.9.4) the larger data points are the average of six 
measurements of each of the three samples, un-spiked urine, urine spiked with 
10-12 M, 10-14 M. The PCA model confirmed that rHuEPO can be detected in urine 
at ultra low concentration.  The model also shows that the spectral data from un-
spiked urine samples are distinguishable from the rest of the data even though 
there were some measurements that are outliers to the model. The separation 
between clusters indicated that the SERS detection is able to differentiate 
between human endogenous EPO and rHuEPO in urine. This discrimination may 
be attributed to the marginally higher affinity of the 3F6 anti EPO antibody 
towards rHuEPO over natural EPO [72, 74, 76, 79-82] 
Figure 4.9.3 SERS spectra of un-spiked urine sample and urine spiked with 10-12, 10-14 
M rHuEPO. 
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            Urine spiked with HUEPO IS vs. rHuEPO IS at 1x10-12 M  
The PCA of urine spiked with HUEPO IS compared with the urine spiked 
with rHuEPO IS at the concentration of 1×10-12 M shows a good separation 
between the two sets of data points and particularly between their average data 
points. (fig 9.4.5)  The ratio between the concentrations of HUEPO and rHuEPO is 
1:2.5 in the sample spiked with rHuEPO (using the same assumptions about 
endogenous EPO concentrations as in the above study). This corresponds with 
28.7% HUEPO in the sample spiked with rHuEPO vs. 100% HUEPO in the other 
sample. 
Figure 4.9.4 PCA of Raman spectra (1515 -1580 cm-1). All urine samples are diluted 
1:1. The larger data points are the average of six measurements. They are well 
separated even though they each contain measurements that are outliers to the 
model. Urine with: PBS pH 7.4, rHuEPO at 1x10-12 M in PBS and rHuEPO at 1x10-14 
M in PBS respectively. 
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Urine spiked with HUEPO IS vs. rHuEPO IS at 1x10-14 M 
The separation of urine spiked with HUEPO IS compared with the urine 
spiked with rHuEPO IS in the PCA at the concentration of 1×10-14 M (fig4.9.6) is 
similar to previous model.  It shows a generally good separation between the two 
sets of data points and their average data points.  The exceptions to this are one 
data point for rHuEPO, which lies close to and overlaps the data points for 
HUEPO; and another data point which is an outlier to the model.  
That a rHuEPO data point is found with the HUEPO data points is not 
surprising as the ratio between the concentrations of HUEPO and rHuEPO is 1: 
0.025 in the sample spiked with rHuEPO (using the same assumptions about 
endogenous EPO concentrations as in the above studies). This corresponds with 
2.5% rHuEPO in the sample spiked with rHuEPO vs. 100% HUEPO in the other 
sample. With such a low concentration of rHuEPO in the sample it is not 
surprising that at least one data point contains no rHuEPO.  However if averages 
are taken of the six data points these two groups are well separated even with 
the outlier and the sample containing no rHuEPO included. 
Figure 4.9.5 PCA of region 1515 -1580 cm-1 from Raman spectra of urine spiked with 
HUEPO or rHuEPO at 1 x 10-12 M. 
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 The Raman instrument used has a very small spot size at one µm, and in 
this type of experiment this is a disadvantage.  The collection of six data points 
and averaging them approximates the large majority of Raman instruments which 
have larger spot sizes.  This experiment shows that this technique can distinguish 
between rHuEPO and HUEPO when only 2.5% of the sample is rHuEPO.  This is a 
very significant improvement upon the current technique where approximately 
71% of the sample must be rHuEPO before it can be detected [125],  and is still 
a significant improvement on the MAIIA technique where 40% rHuEPO is 
required before it can be detected [109].  
  
Figure 4.9.6 PCA of region 1515 -1580 cm-1 from Raman spectra of urine spiked with 
HUEPO or rHuEPO each at 1 x 10-14 M. 
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4.10 PRELIMINARY CONCLUSIONS 
More than 80% of the bare gold nanoparticles were quasi-spherical, with 
the remainder appearing to have joined early in the reduction.  The size range is 
pseudo-monodisperse with 74% of nanoparticles being within one standard 
deviation of the mean size. Two thirds of the nanoparticles had a silica coating 
less than 1.6 nm which is the level quoted by Tian at el [126] as the limit for 
extra enhancement. 
The attachment of the glutaraldehyde linker leads to a considerable 
amalgamation of nanoparticles which is further exacerbated when the antibodies 
are attached.  While limited clustering, producing hotspots, is essential for 
maximum enhancement of the SERS signal, this unrestrained clustering would 
need to be controlled for batch to batch reproducibility.  This could be achieved 
via a bifunctional linker. 
The silica pacification layer and the blocking of unreacted glutaraldehyde 
sites were shown to prevent any non-specific cross reaction. 
The wavenumbers of spectra difference between EPO and unreacted 
nanoparticles was: 422, 440, 525, 725, 760, 800, 915, 1176, 1585 and 1620 cm-
1.  The volume required for the analysis: 10 µL for standard solutions and 30 µL 
for biological fluids, compares favourably with the current technique: 20 mL and 
the proposed MAIIA technique: 5 mL of urine [109].  
The technique was also found to be log linear quantitative: 2 x 10-10 M – 3 
x 10-13 M (LLOQ).  It was linear quantitative at the concentration where EPO is 
naturally found in both urine and serum.   
The nanoparticles were found to react with both HUEPO and rHuEPO and 
to be able to distinguish between the two.  The spectral region between 1519 
and 1580 cm-1 showed this difference.  The technique was able to distinguish 
rHuEPO spiked in urine where the concentration of the recombinant EPO was as 
low as 2.5% of the total EPO.  This is a significant improvement over the current 
techniques (71%) [130] and the new proposed MAIIA technique (40%) [109].   
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Chapter 5: Conclusions and 
Recommendations for Further 
Studies 
The aim of this work was to develop a simple, rapid and cost-effective 
technique for the detection of ultra-trace amounts of simple organic molecules as 
well as complex biomolecules in aqueous and biological fluids.  This chapter 
outlines the outcomes of this work in comparison to other techniques currently 
used or suggested for the detection of ultra-trace amounts caffeine and EPO in 
various matrices, and its many applications such as doping control and quality 
assurance of food products. This chapter also proposes future improvements of 
the presented technique. 
In this work, I have indicated the applicability of the developed SERS 
antibody-functionalised nanoparticle technique to a wide range of applications. 
This was demonstrated by applying the developed technology to both small 
organic molecules (caffeine) and complex biological macromolecules (EPO).  
These two exemplars demonstrated several key advantages of antibody-
functionalised gold nanoparticles over existing technologies, including sensitivity, 
specificity, simplicity, portability and cost effectiveness.  In both the caffeine and 
EPO models, the technique amply qualified the analyte over many orders of 
magnitude (2×10-10 M to 3.5×10-13 M for EPO and 1×10-4 M to 1×10-9 M for 
caffeine).  The achieved levels of quantifications encompassed those required for 
the analysis of the nominated analytes in their relevant field applications (such 
as, food analysis, clinical diagnostics, racing and sports industry).   
In both the caffeine and EPO models, this technique demonstrated 
significant improvement of conservatively six orders of magnitude in lower levels 
of detection for the required sample over the currently used techniques in the 
respective industry: detection of caffeine improved from 2×10-4 g (10 mL at 
9.3×10-5 M) for the FT-Raman technique [40] down to 2×10-13 g (10 μL at 1×10-
10 M); and detection of EPO improved from 7×10-11 g (20 mL at 3x 10-9 M) for 
IEF [84] down to 3×10-16 g (10 μL at 1×10-15 M).   
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This technique simplifies the analysis, as the antibody-functionalised 
nanoparticles utilises the highly selective antibody recognition to bind to the 
target analyte and extract it from solution in a single step capture and pre-
concentration process. Consequently, there is no need for complicated pre-
treatment procedures to isolate and concentrate the analyte from large sample 
volumes, as is required for most of the other currently used methods. Once the 
analyte was bound to the antibody-functionalized nanoparticles, the nanoparticles 
were easily isolated from solution by centrifugation. The washed nanoparticles 
were then subjected directly to trapped analyte detection by SERS.     
The antibody-functionalised gold nanoparticle technique functions as an 
autonomic immuno-separation technique, which eliminates interfering substances 
that co-exist with the target analyte within the sample without a separate 
purification step.  This was evident in the ‘real life’ samples of both the caffeine 
and EPO models, in which no interference was detected by SERS measurement 
from the potentially problematic complex biological matrix in which the analytes 
are naturally found, and the EPO antibody functionalised nanoparticles were 
extracted successfully from skim milk without any cross reaction evidenced by 
indistinguishable Raman spectra and completely intermingled HPCA.   
The enhanced sensitivity attributed to the thin silica coating allowed the 
analytes to be successfully detected and analysed by surface-enhanced Raman 
spectroscopy without the requiring the incorporation of a Raman reporter, which 
represents is a significant improvement over other Raman techniques. As there 
are no extraction procedures required to remove the analyte from the sample 
matrix, this technique eliminates the use of toxic and environmentally unfriendly 
solvents.   
As sensitive and inexpensive portable Raman instruments are becoming 
commercially available, the antibody-functionalised gold nanoparticle technique 
can be adapted for field use as necessary. In this scenario, a kit, including the 
relevant functionalized-nanoparticles and portable instrumentation, could be used 
onsite to concentrate, separate and rapidly analyse the sample for the target 
analyte.   
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This technique has been shown to be a simple rapid and cost-effective 
method, however improvements are needed in the nanoparticle manufacturing 
process. Glutaraldehyde, the linker used in this study, has two aldehyde groups, 
binds nanoparticles bilaterally and thereby forms uncontrollably large nanoparticle 
aggregates.  While some aggregation is necessary for maximum sensitivity the 
degree of aggregation found is counter-productive.  Consequently, there is a 
need to identify a bi-functional linker that will specifically bind the nanoparticle at 
one end and the antibody at the other end.  
A bi-functional linker would allow an increased number of the antibody 
molecules to be loaded onto the nanoparticles, as there would be more surface 
area available on non-aggregated nanoparticles. Increasing the antibody load on 
the nanoparticle surface would increase the analyte capturing capacity and 
effectively increase the SERS signal intensity.  Cysteamine, which forms a strong 
thiol bond with gold and an amide bond with carboxyl groups (antibody), would 
be useful if a polymer based pacification strategy is used, or other suitable linkers 
would need to be found if using silica for this purpose. 
Strategies for more controlled minimal aggregation may need to be 
explored as well, to compensate for loss of aggregation.  Hence, these 
aggregation control techniques would be an important improvement to the 
nanoparticle but would have to be optimised for maximum sensitivity. 
Another optimisation, that would enhance the nanoparticle, is modifying its 
structure to include a magnetic-core. Magnetic-core gold nanoparticles, with an 
iron oxide core and a gold shell allow isolation of the nanoparticles from solution 
by the simple use of a magnetic separator.  Antibody-functionalized, magnetic 
core gold nanoparticles reacted with the target analyte, form a simple magnetic 
separator to extract analytes from the matrix.  This would greatly decrease the 
time required to separate the analyte from complicated biological matrices, from 
an hour with separation via the current centrifugation protocol to just a few 
minutes [131, 132], and would allow technique automation.   
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Magnetic-core gold nanoparticles have another benefit as they improve the 
efficiency of the synthesis and coating procedures by reducing the labour and 
time required for cleanup procedures. 
Nanoparticles improved by inclusion of a magnetic core and efficient and 
optimised aggregation with maximised antibody loading should give the most 
sensitive results.  There is one proviso; this technique has been developed on a 
research grade laboratory-based Raman instrument whereas for the most 
applicability it should be a portable technique that can be taken to the site of 
analysis.  Therefore, its applicability to several models of available portable 
instrumentation must also be evaluated to exploit the advantages of a portable 
technique. 
Applications where this technology could be applied are many and varied.  
Its applicability in anti-doping, for industrial quality control and providence has 
been demonstrated here.  This technique might also be easily adapted and 
applied to medical diagnostics and monitoring, environmental surveillance, food 
toxicology and microbiology, as well as forensic and security applications, just to 
name a few. 
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